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Identification of the environmental reservoir of Mycobacterium ulcerans, the 
etiological agent of Buruli ulcer, within the aquatic ecosystem has been a salient 
research area within the last five years.  Based on extensive environmental sampling 
and elegant laboratory models, associations have been made between the bacterial 
DNA and aquatic invertebrates, biofilms, plants, fish and detritus material captured on 
0.2µm pore filters. These studies have suggested that M. ulcerans is widely
 
distributed 
within many functional feeding
 
groups and may be concentrated through different
 
trophic links; however, the specific route of transmission to humans remains a 
mystery.
 
In this study we have used laboratory models of infection to ascertain the role 
of aquatic invertebrates and fish in M. ulcerans transmission. A biologically relevant 
infection model in which
 
M. ulcerans-infected mosquito larvae were fed to a species of
 
predaceous hemiptera (African Belostomatidae) was used to demonstrate
 
the persistent 
colonization of M. ulcerans and subsequent transmission
 
of bacteria to naïve prey. The 
association of M. ulcerans
 
with specific anatomical compartments showed that M. 
ulcerans
 
accumulates preferentially on the exoskeleton. No difference was found 
between the ability of wild-type M.
 
ulcerans and an M. ulcerans isogenic 
mycolactone-negative mutant
 
to colonize belostomatids. These data show that African 
belostomatids
 
can successfully be colonized by M. ulcerans and support the
 
trophic 
transfer of M. ulcerans within the environment.
  
We have shown that M. ulcerans with 
or without the toxin is not lethal to fish (Medaka) even at high doses following direct 
inoculation. Over time (23wks), infected Medaka do not exhibit any visible signs of 
infection or toxicity and histopathological sections do not reveal significant gross 
pathogenesis. M. ulcerans also appears not to replicate in infected Medaka. We also 
show that fish monocytes are susceptible to nanogram amounts of purified 
mycolactone. This is the first study to demonstrate the possibility of fish as a reservoir 
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Chapter 1: Background and significance 
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1.1 Buruli ulcer disease 
During the last two decades, there has been a re-emergence of the debilitating skin 
disease Buruli ulcer across diverse regions of the world. The disease was named for its 
initial onset in the Buruli district in Uganda, Central Africa (10) and is also known as 
Bairnsdale ulcer in Australia, where the first clinical case was published (32, 47). Until 
recently, much of the public and the medical community were unaware of the disease, 
which has now been reported in over 30 countries worldwide (Fig. 1.1). West and Central 
Africa, especially, Ghana (3, 4, 9), Cote d’Ivoire (31, 36), Nigeria (39) and Congo (54), 
and some parts of Australia are the most affected regions (33, 38, 56). Since 1980, 
significant increases in the incidence of the disease have been reported in these areas with 
new foci also developing in previously non-endemic countries like Togo (37) and Angola 
(7). Other endemic areas of the world include Papua New Guinea (14), Malaysia (41), 
Mexico (3) and French Guiana (20).More than 20,000 cases have been reported in West 
Africa during the last decade (69). 
All age groups are affected by Buruli ulcer, but children under 15 years represent 
the largest disease burden (12). There does not appear to be a sex difference in disease 
incidence among both adults and children, and this is somewhat puzzling since men and 
women have very different roles in the poor rural areas where the disease occurs (12). 
Again there might be a bias in case reporting because of the lack of immediate health care 
facilities and the preference of treatment by herbalists compared to health centers (65, 
66). Buruli ulcer disease is a significant cause of morbidity in affected individuals but 
lethal infections are extremely rare. 
 The disease is focal in nature and has been associated with slow moving and 
stagnant water bodies within endemic areas. There may be pockets of cases within the 
same geographic area that are endemic for the disease within neighboring areas that do 
not have any disease at all. In view of this, the disease burden is difficult to obtain, but it 
is has been estimated that 25% of people in West Africa are affected by the disease (28). 
Some seasonal variation has been thought to exist with the disease. In Australia for 
instance, it was noted that the disease appeared at the end of the autumn or winter (21, 
23). In Uganda, two previous studies have reported a peak of incidence in the low rainfall 
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months between May and September (1, 10). In Ghana and Cote d’Ivoire, the disease is at 
its highest during the months of September and October, which is also the onset of the 
dry season (4, 36). Thus, this seemingly temporal dry period onset of the disease cuts 
across geographical boundaries and could be indicative of a potential risk factor. 
Common to all these areas is the correlation between disease prevalence and 
environmental disturbance, both natural and man made including flooding, sand winning, 
deforestation, and urbanization of previously rural areas (28). 
 
1.2 Causative organism and pathology 
Buruli ulcer is caused by an environmental member of the Mycobacteria family, 
Mycobacterium ulcerans. M. ulcerans is a slow growing bacterium with a generation 
time of about 72 hours. It has a restricted growth temperature range of 28°C to 34°C. It 
stains acid-fast positive with the Ziehl Neelsen stain and typically tends to grow in 
clumps and cords. Molecular analysis shows that M. ulcerans is closely related to M. 
marinum, which causes disease in fish. In addition to its chromosome, M. ulcerans has a 
174-kilobase plasmid, pMUM001, which produces a virulent macrolide toxin, 
mycolactone (17, 58). Mycolactone is composed of an invariant core comprising a 12-
membered macrolactone that is esterified to a highly unsaturated acyl side chain (26). It 
is interesting to note that different congeners of mycolactone are made by the different 
geographical isolates and this directly corresponds to their degree of toxicity. The most 
potent congener, mycolactone A/B, is made by the African and Malaysian isolates. The 
Australian isolates make less toxic mycolactone C whilst the Chinese isolates make 
mycolactone D. Differences in structure are confined to the mycolactone side chain (Fig 
1.2). The core lactone structure is conserved in all mycolactone congeners. 
Recently a group of slow growing mycolactone procuding mycobacteria (MPM) 
that make unique molecules have been identified (Table 1.1) (48, 49, 50). M.liflandii, 
isolated from Xenopus tropicalus and Xenopus laevis frogs, makes mycolactone E (49). 
M. pseudoshottsii and M. marinum DL, isolated from fish in the Chesapeake Bay and Red 
and Mediterranean Sea respectively, make mycolactone F (48, 50). Both forms of 
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mycolactone are cytotoxic to L929 mouse fibroblasts, but are less potent than 
mycolactones produced by M. ulcerans (48). To date, there have been no reported cases 
of human infection by any of these MPMs. Mycolactone producing mycobacteria are all 
though to have evolved directly from M. marinum (42) 
The gross pathology associated with the disease has been attributed to 
mycolactone (16). In addition to this, the slow growth rate directly translates to the slow 
progression of the disease and the restricted low growth temperature makes the skin a 
good target. The disease is characterized by severe subcutaneous necrotic lesions that 
lead to chronic open sores and ulcerations, ultimately affecting bone in extreme cases 
(Fig 1.3). It starts as a painless nodule localized mainly on the extremities and cooler 
parts of affected individuals (21), with exceptional cases on the torso and buttocks (2). As 
the disease slowly progresses, affected areas may progress to the ulcerative stage with 
development of large ulcers with undermined edges (21, 22, 66). Oedema can be 
extensive in some cases and in severe cases there may be bone involvement 
(osteomyelitis) in some cases (62, 66). Bacteria can be identified in all forms of the 
disease. Systemic infection is rarely encountered presumably because the bacteria can 
notgrow at 37°C. 
Unlike M. marinum that produces primarily intracellular infection in humans 
triggering inflammatory responses, cell-mediated immunity (CMI) and delayed type 
hypersensivity (DTH), M. ulcerans is mostly extracellular in acute disease (8). It is 
thought that there might be a transient intracellular state during infection in which M. 
ulcerans is taken up by macrophages and disseminated beyond the site of infection 
followed by subsequent lysis of the immune cells to release extracellular bacteria (53, 
63).  
The difference in the pathology of M. ulcerans compared to other environmental 
mycobacteria, especially its closest relative M. marinum, has been attributed to its 
ongoing reductive evolution. M. marinum and M. ulcerans share 98% nucleotide 
sequence identity, but over the course of evolution M. ulcerans has lost some of its 
genome (51). There are over 700 pseudogenes in M. ulcerans which are intact in M. 
marinum. Over 300 of these pseudogenes have been created by the insertion of two IS 
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elements, IS2404 and IS2606 which are highly represented in M. ulcerans but absent 
from M. marinum. In the most virulent strains of M. ulcerans, the region of difference 1 
(RDI) is absent (63). The RD1 locus encodes a secretory apparatus responsible for 
exporting two antigenic immunomodulatory proteins ESAT-6 and CFP10 (60). In other 
mycobacteria these proteins are crucial in enhancing virulence, and promoting expansion 
and dissemination of the infection (8). Another major event in the evolution of M. 
ulcerans was the acquisition of a large plasmid which produces mycolactone. 
Mycolactone has also been shown to alter the immune system by suppressing the 
production of interleukin-2 (IL-2) and tumor necrosis factor (TNF) thus down-regulating 
T-helper-1 (Th1) responses (19, 40). This leads to a limited inflammatory response 
during the acute and early stages of infection and explains why early detection of cases is 
hampered (18). These events could contribute significantly to the induction and 
regulation of immune responses in hosts (27). 
 Other factors may also contribute to the observed host response to infection such 
as genetics of the affected individuals, previous mycobacterial infection and the extent of 
an individual’s exposure to the bacteria in nature. For instance, it has been found that 
individuals with prior BCG vaccination show reduced rates of ulcers upon infection (1, 
61). However, there is not enough information to accurately outline which of these could 
be determining risk factors for infectivity or variation in the virulence observed. 
 
1.3 Diagnosis, Treatment and Control 
Due to the painless nature of the disease and the lack of epidemiological data on 
the incubation period, early stages of the diease are often ignored. Thus most affected 
individuals report to health centers only after development of a large persistent ulcer. The 
current diagnosis requires biopsies of affected tissue and analysis by Polymerase Chain 
Reaction (PCR). Treatment in Buruli ulcer infections hence seeks to curtail the spread of 
ulcers and repair existing tissue damage to affected areas. In early and intermediate stages 
of the disease, anti-mycobacterial drugs including rifampicin and streptomycin or 
amikacin are highly effective (53, 62). These drugs are used in combination and require 
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administration up to 8 weeks. In more advanced cases where larger lesions are involved, 
complete surgical excision of the affected area remains the most effective treatment 
option (5, 24). Surgery is typically followed by skin grafting and anti-mycrobacterials are 
still administered to prevent relapses and accelerate the healing process. Traditional 
treatments have also been used, and although some may be efficacious they leave behind 
patients with severe scaring and disability. In some cases, in the natural history of the 
disease, the immunosuppressive effect of the toxin is overcome by the host with 
subsequent healing of ulcers (53). Deformities and scarring associated with healing are 
common and this ultimately has a negative effect on the productivity of affected 
individuals. There is a significant amount of stigma also associated with the disease (6, 
55, 56). 
Treatment in hospitals often requires long stays, up to 3 months, during which 
serial surgeries and wound dressings are performed. The average cost of treating a Buruli 
ulcer case was estimated to be US$ 780 per patient in 1994–1996 (68). For example, in 
Ghana in 2001–2003, the median annual total costs of BU to a household by stage of 
disease ranged from US$ 76.20 (16% of a work-year) per patient with a nodule to US$ 
428 (89% of a work-year) per patient who had undergone amputation (65). 
There is no vaccine against Buruli ulcer disease. Current prospects include 
generation of a live attenuated M.ulcerans, sub-unit based vaccines and improvement of 
the BCG vaccine (26). There is evidence that the BCG vaccine may offer a cross-reactive 
protective role, but this has not thoroughly been investigated (1, 26, 61)) 
 
1.4 Transmission 
The mode of transmission of Buruli ulcer remains elusive. Person-to-person 
transmission is rare and there has only been one reported case (11). For over 50 years, all 
the regions of the world that have reported cases of Buruli ulcer have associated the 
disease with proximity to rivers, swamps and watercourses in general. It is of importance 
to note here that even though water bodies have been associated with the disease, the 
clustering of cases does not necessarily correlate with the population distribution along 
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the watercourse. With the ongoing genome reduction of M. ulcerans, it is believed that 
the bacterium is undergoing niche specialization, diverging from being a generalist 
environmental bacterium to a more host specific bacterium. Despite intense investigation 
with transmission , an amplifying reservoir has not been identified. 
M. ulcerans DNA was first detected in the environment in the 1990s by PCR in 
Africa by Franscoise Portaels in Naucorids and Belostomatids (45). M. ulcerans DNA 
has subsequently been detected in a variety of aquatic organisms including 
Belostomatids, Naucorids, Odonates, Coleopterans, mosquitoes, snails and small fish (15, 
29, 34, 45, 51, 57). The DNA has also been detected in biofilm collected from the surface 
of leaves and other inanimate objects and materials captured on 0.2µm pore filters (35. 
67). Animals such koalas and possums have also been found to be naturally infected with 
M. ulcerans (30, 43). Most of the DNA evidence has been based on the detection of the 
insertion elements IS2404 and IS2606. Recently however, it has been shown that these 
sequences are not unique to M. ulcerans and are present in other novel mycobacterial 
species that also contain the mycolactone producing plasmid (26, 48) (Table 1.1 and Fig. 
1.2).  
Various attempts have been made to culture the organism from water, soil, insects and the 
environment at large.These efforts are, however, thwarted by the overgrowth of faster 
growing bacteria in the environment. There was one reported successful culture from a 
Naucorid collected in the Ivory Coast (34). The culture however, could not be propagated 
successfully in the lab and has since died out. More importantly, M. ulcerans has recently 
been isolated from a Gerridae after serial passage of the insect homogenate through mice 
(44). This isolate has been successfully been propagated and characterized. 
Despite the significant efforts made toward identification of potential vectors and 
reservoir species in the environment, the exact mechanism by which the bacterium is 
introduced into unsuspecting hosts is still an enigma. There are three main hypotheses 
involved in the transmission of the bacterium. M. ulcerans has been thought to be 
introduced to persons through a preexisting wound; however this hypothesis has not been 
tested. In 1997, Ross et. Al. published a report indicating that M. ulcerans can be 
aerosolized from suspensions of tap water then be inhaled or ingested by otherwise 
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healthy individuals and subsequently reactivated in areas of the body where the 
temperature is lower or where there has been some recent trauma (23).  
Another hypothesis suggests that humans are primarily infected by traumatic 
introduction of M. ulcerans into the skin through contact with a contaminated 
environment (45). This could occur through injuries from sharp edges of leaves or twigs 
or even insect vectors. The latter hypothesis has been supported with substantial research 
by Marsollier et. Al. In a publication in 2002, Marsollier et. Al. carried out studies on 
naïve Naucorids collected in France, where he infected these insects in the lab with M. 
ulcerans and followed the infection over a period of 90 days. He was able to show that 
the bacteria successfully colonized the insects, causing no growth impairment throughout 
this period. He showed that the insects could transmit the bacteria to mice at the sites of 
trauma when allowed to feed on their tails. In a later experiment, he showed that the 
bacteria were localized in the salivary glands of infected insects. Although these studies 
were of significance, it is difficult to determine their relevance to transmission of Buruli 
ulcer in Africa for a number of reasons; (i) the insect species used were not African 
species, (ii) the primary M. ulcerans used was not representative of the classical M. 
ulcerans from Africa, and (iii) none of the studies have provided comprehensive 
quantitative data on the location of the bacterium within the insect.  
Considering the wide range of organisms that have been found positive for M. 
ulcerans DNA within endemic aquatic water bodies, there is the possibility of a trophic 
relationship between these organisms that could lead to a concentration of the bacteria 
along the food chain and eventually introduction into a likely host. Naucorids and 
Belostomatids are aggressive predaceous hemiptera, known to attack and immobilize a 
wide range of prey even prey larger than themselves (59). Both insect families consume 
small fish. Taking into account the fact that fish in endemic water bodies have been found 
positive for potential M. ulcerans DNA based on detection of the IS2404 insertion 
sequence, it is possible that there may be a transfer of the bacteria via this route. 
Mycobacteriosis in fish has been well documented over the years (13, 32, 
49,46,64). The three most important pathogenic species are M. abscessus, M. fortuitum 
and M. marinum. More recently however, outbreaks of mycobacteriosis have been 
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reported within the Mediterranean and Red Sea and the Chesapeake Bay. These 
infections have been attributed to newly recognized mycobacterial strains that are closely 
related to M. ulcerans including M. marinum DL, M. pseudoshottsii, M. chesapeake and 
M. shottsii (48, 49, 50) (Table 1.1). One striking revelation is that most of these novel 
strains possess a plasmid that encodes for variants of the virulent macrolide toxin, 
mycolactone, similar to the mycolactone produced by M. ulcerans (27, 42) (Fig 1.2). 
Despite the historic association between mycobacteria and fish, no study has been done to 
determine whether M. ulcerans can infect fish, thus being a possible link in the 
transmission process. 
In order to investigate potential reservoirs and vectors of Buruli ulcer, it is 
important to obtain experimental data for their ability to colonize or cause disease in a 
host. The key issues are to determine whether the bacterium colonizes and replicates 
within these organisms. This can best be answered experimentally using laboratory 
models. In this work, we have used an African insect species that has been found to have 
positive PCR results for M. ulcerans in nature and a classical lineage strain of M. 
ulcerans to determine the following: (i) whether M.ulcerans persistently colonizes or 
grows within African predaceous water bugs, (ii) how the bacterium is partitioned within 
external and internal body parts, (iii) whether mycolactone plays a role in insect 
infections, and (iv) whether M. ulcerans can be transmitted by water bugs to prey within 
a food chain. We have also developed an in vivo and in vitro model for understanding M. 
ulcerans pathogenesis in fish by the following; (i) artificially infecting Japanese medaka 
with M. ulcerans, (ii) determining the pathogenicity of M. ulcerans in medaka, (iii) 
determining the role of mycolcatone in medaka infection (iv) determining whether M. 
ulcerans can actively colonize and replicate in Medaka and (v) determining the 
cytotoxicity of mycolatones to fish macrophages. This is the first study to address the 
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Figure 1.2: Mycolactone variations represented in naturally occurring isolates. The 
core is the same in all these molecules with variations occurring in the side chains. (Pidot 
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2.1 Insect colonization studies 
2.1.1. Bacterial strains and growth conditions 
The strains used in this study and their sources are shown in Table 2.1. The 
MU1615 strain is a well-characterized Malaysian human isolate with physical and 
biochemical properties very similar to the genome strain Agy99 from Ghana and makes 
mycolactone A/B. Transposon mutagenesis (12) was used to generate the mycolactone 
negative mutant MU1615::Tn118 with an insertion in the FABH gene (mup045). 
MU1615g and Mu1615::Tn118g express a green fluorescent protein via an integrating 
vector psm5 (13). By using this method, the GFP gene is inserted into the chromosome of 
MU1615 in the phage attachment site (att) and has no effect on the virulence of the 
bacterium. All strains were grown to mid-log phase in Middlebrook 7H9 (M7H9) media 
supplemented with 10% oleic acid-albumin-dextrose enrichment (OADC) {DIFCO}. M. 
ulcerans and M. marinum 1218 strains were incubated at 32°C the MMDL strain was 
incubated at room temperature and the XL5 strain was incubated at 28°C with 5% CO2.  
2.1.2. Inoculum preparation 
The total number of bacteria used for the infections was determined via colony 
forming units (cfu). One loop-full of bacteria growing at exponential phase was 
emulsified in 0.01% sodium dodecyl sulfate, and clumps were broken by being passaged 
through a 25-gauge needle 15 times. One hundred microliters of the resulting suspension 
was plated on M7H9 agar medium supplemented with 10% OADC (Difco) and incubated 
at 32°C for 6 weeks to determine cfu. 
 
2.1.3. Aquatic insects 
Adult belostomatids (Appasus sp. [Diplonychus sp.]), 1- to 3-cm long were 
collected from aquatic sampling sites in Ga district, Ghana. Insects were housed 
individually in deep petri dishes filled with double-distilled water and maintained under a 
12-h light and dark photoperiod at 28°C. Insects were fed either midge larvae 
(Chironomidae) or blowfly larvae (Diptera: Calliphoridae) (Phormia regina) every other 
day, and the housing water was changed at the same time. Mosquito (Ochlerotatus 
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triseriatus) egg rafts were obtained from Michigan State University. The egg rafts were 
submerged in double-distilled water so that they could hatch into larvae in about 3 days. 
Larvae were maintained on powdered fish food each day until they developed into third 
instars, when they were fed bacteria and used for infection. Because some belostomatids 
were collected from areas endemic for Buruli ulcer and M. ulcerans DNA has been 
detected in a small number of belostomatids from West Africa, 110 belostomatids were 
analyzed by using microscopy and PCR for the presence of M. ulcerans DNA. All insects 
tested were PCR negative for M. ulcerans and therefore were used as negative controls. 
2.1.4. Experimental infection of insects 
Mosquito larvae infected with MU1615g via feeding were used as the primary 
prey for adult belostomatids in these studies (Fig 2.1) . Infected prey were prepared by 
starving the naïve larvae (Ochlerotatus triseriatus) for 24 h and then transferring them to 
a fresh container containing 10
6
/ml M. ulcerans bacteria in 10 ml of double-distilled 
water, where larvae were allowed to feed on fluorescently tagged M. ulcerans for 24 h. 
Five representative larvae were removed and analyzed for the presence of M. ulcerans by 
using light (acid-fast stain) and fluorescent microscopy. At this time point, the guts of 
virtually all larvae were packed with M. ulcerans. Three infected larvae were then fed to 
each belostomatid that had previously been starved for 7 days. There were 36 adult 
belostomatids per bacterial strain used. Twenty-four hours after infection, each insect was 
transferred to a new petri dish and maintained on chironomid (Diptera: Chironomidae) 
midge larvae for the duration of the study period. The water was changed each time 
insects were fed. 
2.1.5. Detection of M. ulcerans in insect tissues 
For infection studies, 36 insects were used for each M. ulcerans strain tested. At 1 
day, 30 days, and 60 days post infection (p.i.), 12 insects were sacrificed for analysis. The 
24-h time point was chosen to determine the rate of infection, whereas the later time 
points were chosen to detect viability, colonization, and multiplication of the bacteria 
within the insects. At each time point, individual belostomatids’ internal organs were 
carefully removed, and the salivary gland, gut, head, thorax, and forearms (Fig 2.2) were 
homogenized in 200 µl of 1 M Tris-HCl buffer [pH 7.5]. For quantification of the 
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bacteria, four 10-fold dilutions were made of each anatomical section, and smears were 
made for acid-fast staining and fluorescent microscopy. Acid-fast bacilli (AFB) were 
viewed with a light microscope (Olympus BX51/BX52). Wet mounts of each section 
were viewed using a fluorescent microscope (Nikon Eclipse E400) equipped with a 
standard epifluorescent attachment filter set for the detection of the fluorescently labeled 
bacteria. Although AFB microscopy provided better visualization of M. ulcerans 
morphology, the presence of fluorescently labeled M. ulcerans was required for scoring a 
belostomatid positive for M. ulcerans as determined by microscopy. For scanning 
electron microscopy, infected insects were vacuum dried, sputter coated with gold using a 
SPI-Module sputter coater for 10 s, and mounted on carbon-coated metal stubs. Imaging 
was performed on a Zeiss 1525 field emission scanning electron microscope equipped 
with a GEMINI field emission column.  
For recovery of viable bacteria from the infected insects, 100 µl of each insect 
section homogenate was decontaminated via the modified Petroff’s method (15). Briefly, 
150 µl of 4% NaOH was incubated with 100 µl of insect homogenate for 15 min, 
followed by a 15-min incubation with 800 µl of sterile saline of the recovered pellet. The 
resulting pellet, after centrifugation at 3,000 µg, was resuspended in 100 µl sterile saline 
and plated on M7H9 agar plates supplemented with 10% OADC supplement (Difco), 
chloramphenicol (20 mg/ml), and cycloheximide (20 mg/ml). 
2.1.6. Transmission of M. ulcerans infection to blowfly larvae via feeding 
 Twelve infected belostomatids removed at 1 day, 30 days, and 60 days p.i. were 
allowed to feed individually on a single blowfly larva (Phormia regina). Larval exuviae 
were collected immediately, homogenized as described above, and analyzed by using 
microscopy and PCR for the presence of M. ulcerans. As controls, uninfected 
belostomatids were also allowed to feed on larvae and were analyzed for the presence of 
M. ulcerans. 
2.1.7. DNA extraction and PCR analysis 
  DNA was extracted from insect and larval homogenates with the UltraClean soil 
DNA extraction kit (Mo Bio Laboratories) according to the manufacturer’s instruction. 
The enoyl reductase (mlsA) gene was chosen to determine the presence of mycobacterial 
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DNA in insect tissues as previously described (14). Five microliters of each DNA sample 
was amplified with the mlsA primer pair 5’-GAGATCGGTCCCGACGTCTAC-3’ and 
5’-GGCTTGACTCATGTCACGTAAG-3’ in 50-µl PCR mixtures using the GoTaq 
polymerase buffer system (Promega). Each reaction mixture contained 36.7 µl double-
distilled water, 5 µl GoTaq green master mix (400 µl of each deoxynucleoside 
triphosphate, 3 mM MgCl2, blue and yellow dyes), 1 µM of forward and reverse primers, 
1.5 U of GoTaq polymerase, and 5 µl of DNA template. Cycling was performed in a 
Mastercycler gradient thermal cycler (Eppendorf) as follows: 95°C for 5 min; 35 cycles 
of 95°C for 1 min, 55°C for 1 min, and 72°C for 1 min; and 72°C for 10 min. Nine 
microliters of each reaction mixture was analyzed on 1.5% agarose gels in 1µM Tris-
acetate-EDTA stained with 1 µg/ml ethidium bromide for visualization of amplicons. 
2.1.8. Statistical analysis 
Statistics were calculated using STATA version 10.0. For the analysis of numbers 
of anatomical sections positive for microscopy and PCR, the Mann Whitney rank sum 
test was used.  For the analysis of differences between MU1615g and MU1615::Tn118g 
infected belostomatids, P values were calculated for the number of insects positive for 
bacteria as determined by either microscopy or PCR using the Mann-Whitney test for 
comparison of two groups. Z values correspond with the strains used. A positive value 
indicates greater significance with MU1615g than MU1615::Tn118g. A negative value 
means greater significance with MU1615::Tn118g than MU1615g. 
2.2. Insect microflora studies 
2.2.1. Aquatic insects  
Adult belostomatids (Appasus sp. [Diplonychus sp.]), 1 - 3cm long were collected 
from aquatic sampling sites in Ga district, Ghana.  Adult naucorids (Naucoris sp.), 0.5 - 1 
cm long were also collected from aquatic sampling site in Ga district, Ghana. Insects 
were housed individually in deep petri dishes filled with double-distilled water and 
maintained under a 12-h light and dark photoperiod at 28°C. Insects were fed either 
midge larvae (Chironomidae) or blowfly larvae (Diptera: Calliphoridae) (Phormia 
regina) every other day, and the housing water was changed at the same time. 
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2.2.2. Culture-dependent methods of isolating bacteria 
Ten uninfected belostomatids and naucorids were used for this study. The external 
parts of the insect were surface sterilized with 70% ethanol prior to dissection of salivary 
glands, head, thorax and gut. The sections were homogenized in 500 µl of sterile saline 
with a mortar. One hundred microliters of the resulting homogenate was aliquoted out 
and serially diluted 10-fold up to 10
-5
. Fifty microlitres of the resulting solutions was 
plated directly onto Middlebrook 7H9 (M7H9) media supplemented with 10% oleic acid-
albumin-dextrose enrichment (OADC) {DIFCO} and LB agar plates (DIFCO). The 
plates were incubated at 37°C for 24 – 48 h. The M7H9 mycobacterial media was used to 
isolate bacteria that were likely to compete with M.ulcerans recovery from infected 
insects. The nutrient rich LB media was used to isolate dominating and supporting 
microflora from the insects.  
Plates were screened for bacterial growth. Forty colonies from each media type 
were selected for sub-culture and further screening. After three sub-culture passages, 47 
colonies were randomly selected based on colony morphology, color, elevation, size, 
margin and frequency of occurrence. The morphology of the bacterial isolates was also 
determined by gram staining. The selected bacterial isolates were further characterized 
based on their distinctive metabolic properties. The isolates were plated individually onto 
selective media including gelatin, urea slants, triple sugar iron slants, MacConkey agar 
and Simmons citrate agar to identify their ability to produce gelatinase and urease, 
ferment sugars and lactose and utilize citrate as the sole carbon source respectively. 
 2.2.3. Antibiotic susceptibility testing 
A Kirby Bauer test (2) was also conducted to identify susceptibility of bacteria to 
various antibiotics. Each bacterial isolate was cultured in LB broth medium for 24 hours. 
One hundred microliters of the resulting broth cultures was spread plated onto a Mueller 
Hinton agar plate and tested against 12 different antibiotic discs: Ampicillin 25 µg, 
Carbenicillin 100 µg, Streptomycin 10 µg, Tetracyclin 10 µg Chloramphenicol 10 µg, 
Gentamycin 10 µg, Ciprofloxacin 30 µg, Clindamycin 30 µg, Penicillin 10 units, 
Amikacin 100µg and Sulphonamides10 µg were equidistantly dispensed on the M-H 
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plates. The plates were incubated for 24 h at 37°C and the zones of inhibition of bacterial 
growth were measured and recorded as described.  
2.2.4. Culture independent methods of bacterial identification 
Bacterial DNA was isolated as described above from the insect homogenates. The 
16S ribosomal RNA gene was amplified using universal bacterial primers (9). The PCR 
reactions were performed according to the following; 5µl of each DNA sample was 
amplified with the forward primer UnivBacF  5’-AGGAGGTGATCCAACCGCA-3’ and 
reverse primer UnivBacR 5’-GAGGAAGGTGGGGAT-3’ in 50-µl PCR mixtures using 
the GoTaq polymerase buffer system (Promega). Each reaction mixture contained 36.7 µl 
double-distilled water, 5 µl GoTaq green master mix (400 µl of each deoxynucleoside 
triphosphate, 3 mM MgCl2, blue and yellow dyes), 1 µM of forward and reverse primers, 
1.5 U of GoTaq polymerase, and 5 µl of DNA template. Cycling was performed in a 
Mastercycler gradient thermal cycler (Eppendorf) as follows: 95°C for 5 min; 35 cycles 
of 95°C for 1 min, 55°C for 1 min, and 72°C for 1 min; and 72°C for 10 min. Nine 
microliters of each reaction mixture was analyzed on 1.5% agarose gels in 1µM Tris-
acetate-EDTA stained with 1 µg/ml ethidium bromide for visualization of amplicons. 
2.2.5. Cloning and sequencing 
The amplified partial 16S rRNA gene PCR products were cloned into vectors by 
ligating them into PCR 2.1 TOPO vector system (Invitrogen) according to the 
manufacturer’s instructions. The ligated products were transformed into competent E. 
coli DH5α vectors and resulting transformants were grown on LB plates supplemented 
with100 μg mL-1 each of ampicillin, X-gal and Isopropyl β-D-1-thiogalactopyranoside. 
Isolated white colonies that grew upon 24 h of incubation were selected for plasmid DNA 
extraction (Qiagen mini prep) and subsequent sequencing. Sequencing reactions were 
performed using the Big Dye terminator v3.1 kit (Applied biosystems). Purified DNA 
was sequenced using the M13 forward (5’-GTAAAACGACGGCCAG-3’) and reverse 
primers (5’-CAGGAAACAGCTATGAC-3’) which flank the inserted partial 16SrRNA 





2.3 Fish In vitro Studies 
2.3.1. Tissue culture 
The adherent carp monocyte cell line CLC (European Collection of Cell Cultures 
no. 95070628) was a kind gift from Jeffery Cirillo (Texas A&M Health Science Center). 
Cells were maintained at 28°C and 5% CO2 using high glucose MEM (Gibco) 
supplemented with 10% essential amino acids (Gibco), 10% heat-inactivated fetal bovine 
serum (Gibco) and 2mM L-Glutamine as previously described in (4). Cytopathicity 
assays were performed in 24-well tissue culture plates. 
2.3.2. Mycolactone sensitivity assay 
Mycolactones from MU1615, MMDL, and XL5 were extracted as described 
previously in (6, 10). Briefly, lipids were extracted with chloroform –methanol (2:1, 
vol/vol), and phospholipids were removed by precipitation with ice-cold acetone to 
obtain acetone-soluble lipids (ASLs). Acetone soluble lipids were serially diluted in 
tissue culture medium and added to cells in a 24-well tissue culture plate. Cytopathicity 
was defined as the minimal concentration of mycolactone necessary to produce cell 
rounding in 24 h and loss of the monolayer by 48 h (1). 
2.3.3. LDH release and apoptosis 
Fish monocytes (CLC cells) were assayed for cell death via apoptosis and 
necrosis. Apoptosis and necrosis were measured using a colorimetric kit from Promega as 
previously described (1). Briefly, cells were suspended in culture media and seeded in a 
96 – well tissue culture plate. The release of cytoplasmic lactate dehydrogenase from 
mycolactone treated and permeabilized cells was measured at 24 h p.i. using the 
colorimetric kit following the manufacturer’s instructions. Background release of LDH 
was determined from lyses of ethanol treated cells according to the manufacturer’s 
protocol. The percentage of LDH release was then computed using the following 
calculation: [(release of LDH from mycolactone treated cells – background release from 




Apoptosis of mycolactone treated CLC cells was measured at 24 h p.i. by using the Cell 
Death Detection Plus enzyme-linked immunosorbent assy (Roche, Indianapolis, IN) as 
described previously in (1). Apoptosis was determined as fold enrichment of 
nucleosomes [(measurement of DNA-histone complex from treated cells/background 
measurement of untreated cells)]. 
 
2.4 Fish In vivo Studies 
2.4.1. Medaka aquaculture 
Japanese Medeka used in this study were obtained from Don Ennis (University of 
Louisiana, Lafayette, LA, USA). Medaka were maintained in the laboratory in aquaria at 
28°C, as described in (3). Fish were infected with mycobacteria and maintained post 
infection in a BSL-2 laboratory at 28°C. 
2.4.2. Experimental design 
Two infection experiments were performed in this study as outlined in Figure 
2.4A and B. Bacterial inocula was prepared as described above and diluted in PBS to 




. Medaka were anaesthetized with tricaine 
methanesulphonate (MS-222) (0.0175%) and injected with 30µl of bacterial suspension 
at respective doses.  Sham infections were also performed where medaka were inoculated 
with 30µl of sterile PBS. All fish were maintained separately under similar environmental 
conditions and monitored for survival, mortality, gross behavioral changes and gross 
morphological pathology. 
2.4.3. Histopathology 
At the set time points (Figure 2.4A and B), 1-3 infected fish were euthanized 
using an overdose of tricaine methanesulphonate (MS-222) (0.1%). Fishes were 
processed whole in 10% neutral-buffered formalin followed by embedding in paraffin 
wax. Thin sections of the paraffin embedded fish were made and stained with 
hematoxylin and eosin (H&E) and Ziehl-Neelsen acid fast stain. The morphological 
pathology and presence of acid fast bacilli (AFB) present in the fish tissues was scored 
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between bacterial strains used and within doses of inoculum delivered respectively. 
―Sham‖ control infected fish were sacrificed and subjected to similar treatments for 
comparison. 
2.4.4. Microscopic evidence of microbial colonization  
Between 4 to 9 bacteria-infected Medaka were euthanized as described above at 
the time points shown in figure 2.4A and B. Each fish was dissected by making a single 
anterior to posterior incision along the abdomen followed by removal of the kidney, liver, 
spleen, gut and heart. Whole organs of fish infected with fluorescently labeled bacteria 
were inspected microscopically as described in (3). Briefly, fish organs were placed in a 
petri dish and observed for fluorescence using a Nikon SMZ800 (Nikon, Tokyo, Japan) 
stereomicroscope equipped with X-cite TM 120 for fluorescence. The organs as well as 
the remaining fish carcass were kept separate and homogenized in 500µl of M7H9 broth 
media supplemented with 100µg/ul cyloheximide, 20µg/ul chloramphenicol and 25µg/ul 
ampicillin. For detection of AFB in the dissected organs, smears were made from the 
homogenized suspensions and stained using the Zeihl-Neelsen technique. AFBs were 
viewed light microscopy using an Olympus BX51 microscope (USA). Wet mounts of 
representative organs were viewed using a Nikon ECLIPSE E400 fluorescent microscope 
for the detection of the fluorescently labeled bacteria.  
2.4.5. PCR analysis of infected Tissue  
DNA was extracted from organ homogenates using a protocol adapted from 
Lamour and Finely (8). Amplification of the enoyl reductase (mlsA module of the 
mycolactone plasmid) gene was chosen to determine the presence of MU1615g and 
MU1615::Tn118g DNA in fish tissues. The early secreted antigen protein (ESAT-6) gene 
was chosen to determine presence of MMDL240490 and MM1218 in fish tissues. Two 
and a half microlitres of  each respective DNA sample  was amplified with the mlsA 
primer pair; 5’– GAGATCGGTCCCGACGTCTAC-3’ and 5’-
GGCTTGACTCATGTCACGTAAG-3’  or  the ESAT-6 primer pair; 5’ – 
GACAGCAGCAGTGGAATTTCG – 3 and  5’ – CTTCTGCTGCACACCCTGGTA – 3 
in 25µl polymerase chain reaction mixtures using the GoTaq polymerase-buffer system 
(Promega). Each reaction contained 18.3µl double-distilled water, 2.5µl GoTaq green 
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master mix (400µl of each deoxynucleoside triphosphate, 3mM MgCl2, blue and yellow 
dyes), 0.5µM of forward and reverse primers, 0.75U GoTaq polymerase each and 5µl of 
DNA template. Cycling was performed in a Matercycler gradient thermal cycler 
(Eppendorf) as follows:  95°C for 5 min; 35 cycles of for 95°C for 1 min, 55°C for 1 min 
72°C for1 min; and 72°C for 10 min. Seven microlitres of each reaction mixture was 
analyzed on 1.5% agarose gels in 1X Tris-acetate-EDTA stained with 1µg/ml ethidium 
bromide for visualization of amplicons. 
For quantitative PCR, DNA was extracted as described before. Genome forming 
units of MU1615g and MU1615::Tn118g in fish tissue were quantified by the 
exponential detection of expression levels of an internal probe designed for the enoyl 
reductase gene. Five microlitres of representative DNA was amplifed with the mlsA 
primer pair; 5’- CGCCTACATCGCTTTGG -3’ and 5’- ATTGAATCGCAGCCATACC 
-3’ and an internal probe; 5’ -TET CTGATCCATGCCGGCA MGBNFQ -3’  in 25µl 
polymerase chain reaction mixtures using the fluorescent Taqman PCR system. Each 
reaction mixture contained 3µl double-distilled water, 12.5µl environmental mastermix, 
1µl each of forward and revers primers and 2.5µl probe. Cycling and detection of the 
Taqman fluorophore was performed in an Applied Biosystems Division 7700 
thermocycler and sequence detector. 
2.4.6. Statistical analysis 
Statistics were calculated using SPSS version 17 and GraphPad Prism version 4 
software. For the analysis of cytotoxicity via apoptosis and LDH release, the Students t-
test was used to determine significant differences between the congeners of mycolactone 
used. For the analysis of percent survival of Medaka post infection with different 
mycobacteria, standard deviations were computed to determine significance. For analysis 
of numbers of infected organs that were AFB and ER-PCR positive within and between 
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Table 2.1. Mycobacterial strains used for this study 
 
Strain  Species  Host  Geographic 
origin  
Charateristics Reference or 
source  
MU1615  M. ulcerans  Human  Malaysia  Wild-type strain. Makes Mycolactone A/B ATCC
a
  
MU1615g M. ulcerans Human Malaysia Wild-type strain. Makes Mycolactone 
A/B. Intrinsically expresses green 




MU1615::Tn118  M. ulcerans  Human  Malaysia  Mycolactone negative mutant due to 





MU1615::Tn118g M.ulcerans Human Malaysia Mycolactone negative mutant due to 
insertion in FabH gene via transposon 
mutagenesis. Intrinsically expresses green 




MU01G897 M. ulcerans Human French Guyana Wild – type. Makes mycolactone A/B 4 
1218  M. marinum  Salt water fish  United States 









Red Sea Israel  Wild-type strain. Makes mycolactone F 11  




Wild – type strain. Makes mycolactone E. 10  
aATCCa – American Type Cell Culture 35840 





Figure 2.1: Location of acid-fast (bright-field microscopy) and GFP-labeled 
(epiflourescence microscopy) MU 1615g in mosquito (Ochlerotatus triseriatus) larva 
gut.  
Total magnification = 1000X   
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Figure 2.2: Images of dissected belostomatid, showing the relative sizes of the 
following insect compartments assayed in this study: head (A), raptorial arms (B), 

























Chapter 3: Persistent Association of Mycobacterium ulcerans 
with West African Predaceous Insects of the Family 
Belostomatidae 
This chapter is a lightly revised version of a paper by the same name published in the 
journal Applied and Environmental Microbiology in 2008 by Lydia Mosi, Heather 
Williamson, John R. Wallace, Richard Merrit and Pamela L. C. Small: 
 
 
Lydia Mosi, Heather Williamson, John R. Wallace, Richard W. Merritt, and P. L. C. 
Small. Persistent Association of Mycobacterium ulcerans with West African Predaceous 
Insects of the Family Belostomatidae. Applied and Environmental Microbiology Vol. 74, 
No. 22. 7036-7042 
 
 
My use of ―we‖in this chapter refers to my co-authors and myself. My primary 
contributions to this paper include (1) selection of the topic and development of the 
experiments, (2) Most of the gathering and interpretation of literature, (3) statistical 





Mycobacterium ulcerans disease (Buruli ulcer) continues to be one of the most 
debilitating cutaneous diseases in West Africa. Although the distribution of the disease is 
global and affects people of all ages, the burden of disease is most severe in West Africa, 
where Buruli ulcer is an emerging disease. In West Africa, cases typically occur among 
rural, economically deprived populations (11, 31). M. ulcerans is an environmental 
pathogen; however, the method of transmission from the environment to humans remains 
elusive (5, 11, 32). Person-to person transmission of Buruli ulcer is extremely rare, and a 
large body of evidence implicates exposure to slow moving or stagnant water as the most 
universally defined risk factor for infection (23, 25). A striking characteristic of the 
disease in all regions is its discontinuous focal distribution. Villages where the disease is 
endemic and those where it is not endemic may be found within a few kilometers of each 
other along a waterway (23, 25, 26).The absence of the disease in arid parts of the world 
strongly suggests that environmental constraints may limit the distribution of disease. In 
addition, there is a strong association of the bacterium within aquatic ecosystems.  
The possibility of the bacterium being concentrated through trophic links and 
ultimately delivered to an unsuspecting host, via a vector or some other unknown route, 
has been suggested by several investigators (6, 14). A major advance in understanding 
transmission occurred with the detection of M. ulcerans DNA in predaceous insects 
(Naucoridae and Belostomatidae), leading to the hypothesis that insects may be involved 
in the transmission (20). Naucorids and belostomatids are aquatic hemiptera that exploit a 
wide range of prey, including snails, fish, anuran larvae, and other terrestrial and aquatic 
insects (29). Both insect groups are found worldwide near vegetative areas of stagnant 
water bodies. Although they do not feed on humans, they can bite if they are disturbed 
and for this reason are called ―toe biters.‖ Subsequent work from Ghana and Cote 
d’Ivoire has confirmed the presence of M. ulcerans DNA in a large number of aquatic 
invertebrate and vertebrate taxa (6, 18, 20, 21). None of the predaceous hempitera that 
were found to have positive PCR results for M. ulcerans DNA in Africa are 
hematophagous, and the percentage of biting hemiptera is often quite low in areas where 
the disease is endemic (2).There have been numerous unsuccessful attempts to culture the 
bacterium from the environment due to competition from other, faster-growing 
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environmental bacteria. A major breakthrough occurred with the successful culture of M. 
ulcerans from a water strider (Gerridae) collected in Benin by Francoise Portaels et al. 
(22).  
In addition to extensive field work on the occurrence of M. ulcerans in natural 
environments, the potential role of biting hemiptera as vectors of M. ulcerans has been 
extensively explored in a set of elegant laboratory studies conducted by Laurent 
Marsollier et al. (13, 15, 16). In these studies, dipteral larvae (Phormia terrae-novae) were 
injected with suspensions of M. ulcerans and subsequently fed to Naucoris cimicoides, 
collected from swamps in France (13). Marsollier and colleagues showed from these 
studies that M. ulcerans successfully colonized the insect over a period exceeding 90 
days, causing no growth impairment or death of the insect. More interestingly, they 
showed through microscopy that whereas wild-type bacteria could be detected on the 
raptorial arms of naucorids, the majority of organisms were localized in the salivary 
glands of the insect. Finally, Marsollier et al. (15) also presented data supporting the role 
of the M. ulcerans cytotoxic macrolide toxin, mycolactone, in colonization of the insect.  
Although these studies were of significance, it is difficult to determine their 
relevance to transmission of Buruli ulcer in Africa for a number of reasons. First, the 
species of Naucoridae used was from France, not Africa where Buruli ulcer is endemic. 
Second, the bacterial strain used for most of these studies is a member of the ―ancestral‖ 
lineage of M. ulcerans rather than a member of the ―classical‖ lineage associated with 
severe Buruli ulcer in Africa and Malaysia (12). To investigate the ability of M. ulcerans 
to colonize aquatic African hemiptera, we infected adult belostomatids collected in 
Ghana with a ―classical‖ isolate of M. ulcerans. We also employed a mycolactone-
negative mutant of M. ulcerans to determine the role of mycolactone in insect 
colonization. We showed that belostomatids can be persistently colonized by both 
mycolactone-producing and mycolactone-negative M. ulcerans; however, we obtained no 
evidence of replication within internal insect organs. We showed extensive colonization 
of the exoskeleton and showed that M. ulcerans is transmitted to prey via feeding. In our 
infection model, we demonstrated the significance of trophic-level transfer of M. 
ulcerans in the environment in which naturally infected mosquito larvae successfully 
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passed M. ulcerans up the food chain. These results provide a useful model for beginning 
to understand the ecology ofM. ulcerans in West Africa. 
 
3.2 Results 
3.2.1. Mycobacterium ulcerans exhibits prolonged infection in African Belostomatids.  
We showed that throughout the 60-day study period, all of the belostomatids that 
had been infected with M. ulcerans 1615 GFP were shown to be positive for the bacteria 
as determined by either microscopy, PCR analysis, or both (Table 3.1). Based on 
microscopy and PCR, there was a 100% infection rate as determined by the presence of 
M. ulcerans in 12/12 insect guts after 24 h (Table 3.2 ). This amount declined 
significantly (P = 0) to 9% at 30 days p.i., with only one gut being AFB positive, and rose 
slightly to 30% at 60 days. This increase was not statistically significant (P = 0.8357). 
There was a low infection rate of the salivary glands assayed at all time points, with a 
mean of 12% insects shown to be positive for bacteria as determined by microscopy for 
M. ulcerans. By using PCR analysis, however, the average rate of infectivity over time 
was much higher (63%). The rates of infection in the head, raptorial arms, and thorax 
followed similar patterns. The largest number of M. ulcerans-positive insects for these 
three anatomical sections averaged 88% and occurred at 30 days p.i. This increase 
between 1 day p.i. and 30 days p.i. was statistically significant, with P values of 0.05, 
0.0003, and 0.0004, respectively. Between 30 days and 60 days, even though there was a 
decrease in the number of insects that were positive for bacteria on the head, raptorial 
arms, and thorax, the difference was not significant.  
There was some discrepancy between PCR and microscopy results for the 
percentage of insects positive for M. ulcerans (Tables 3.2, 3.3). There were significantly 
more insects shown to be positive as determined by PCR analysis in the head, raptorial 
arms, and salivary glands at 1 day p.i. (P = 0.02, 0.001, and 0, respectively). By using 
microscopy, at 30 days p.i. there were significantly more insects shown to be positive for 
bacteria on the head, raptorial arms, and thorax (P = 0.0006, 0.02, and 0.0006, 
respectively). Contrary to the decrease in the number of insects that were positive for M. 
ulcerans at 60 days p.i. in the gut, there was a significant  increase determined by PCR 
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analysis (P = 0.002). All insect sections that were shown to be positive for bacteria by 
bright field microscopy were also positive for GFP bacilli, thus strengthening the 
observation. A total of three insects died prior to the day 30 and day 60 time points; 
however, the deaths were not attributed to any effect of M. ulcerans but rather to natural 
causes. A similar death rate occurred among the uninfected insects.  
3.2.2. M. ulcerans increases in external compartments and decreases in internal organs 
over 60 days. 
 In order to quantitatively determine multiplication of M. ulcerans within the 
infected insects, dissected anatomical sections were homogenized, decontaminated by the 
modified Petroff’s method, and cultured on M7H9 medium supplemented with OADC 
and 20µg/ml each of chloramphenicol and cycloheximide. These efforts, however, were 
mostly frustrated by the overgrowth of faster-growing bacteria and fungi present in many 
insects. The salivary glands produced little bacterial growth and no isolates of M. 
ulcerans. For this reason, a semi quantitative method for obtaining evidence for the 
growth of M. ulcerans was employed based on detection and enumeration of acid-fast 
and GFP positive bacilli present in dilutions of insect section homogenates. Results from 
these studies showed that the bacterial load on the exoskeleton (head, raptorial arms, and 
thorax) was greater than that in the internal organs (salivary glands and gut) at all time 
points (Fig. 3.1, 3.2, 3.3). Since the primary infection of the belostomatids was performed 
orally, it was expected that the insect guts would have a large amount of bacteria 
compared to other anatomical sites at early time points, and this phenomenon was indeed 
observed. However, bacterial density dropped significantly (P = 0.0003) in the gut by the 
60-day time point. The mean bacterial density within the salivary gland remained below 
10 detectable bacterial cells for all time points without any significant changes. In 
contrast, anatomical sections of the insect covered by a substantial exoskeleton showed a 
significant and steady increase in density of detectable bacteria over the 60-day study 
period with as many as 1,000 bacterial cells seen per viewing field at 1000× 





3.2.3. M. ulcerans is efficiently transmitted from infected belostomatids to blowfly larva 
through feeding 
Belostomatids feed by grabbing and immobilizing prey with their raptorial arms 
and sucking out prey contents with their stylet (28). In order to determine the ability of 
M. ulcerans-infected belostomatids to transmit M. ulcerans through grabbing and biting, 
blowfly larva exuviae, which were fed to infected belostomatids, were analyzed for the 
presence of M. ulcerans by using microscopy, PCR analysis, and culture (Fig. 3.4). Each 
insect prior to being sacrificed at 1 day, 30 days, and 60 days p.i. was given a naïve 
blowfly larva. Larva exuviae collected at each time point were pooled for analysis. M. 
ulcerans could be detected by using microscopy (Fig. 3.5) and PCR analysis (data not 
shown) in all exuviae. Even 60 days after infection with M. ulcerans, belostomatids were 
still able to transmit M. ulcerans to naïve blowfly larvae through feeding. The attempt to 
culture back from the blowfly larva exuviae was unsuccessful even after decontamination 
of samples due to overgrowth of native bacteria. In this experiment, 100% infectivity of 
maggot exuviae was found as determined by both PCR and microscopy, indicating a 
direct transmission of bacteria from the insects to their prey. 
3.2.4. Mycolactone is not required for the colonization of belostomatids. 
Insects that were infected with the mycolactone-negative strain MU1615::TN118g 
showed patterns of persistence within African belostomatids similar to those of 
MU1615g bacteria (Tables 3.1, 4 and 5). As stated earlier, each infected insect was 
dissected into five anatomical sections, homogenized, and assayed for the presence of the 
bacteria. There was a 100% infectivity of insect guts 1 day p.i. as determined by both 
microscopy and PCR. This efficiency decreased steadily over time to 25% insects at 60 
days p.i. as determined by microscopy. However, PCR analysis showed there was a 
significant increase in the number of insect guts that were positive for bacteria (P =0.04). 
Similarly, the salivary glands of the insects were the least infected, and there were no 
significant differences in the number of positive results as determined by either 
microscopy or PCR. There were comparable numbers of insects that were positive for 
bacteria on the head, raptorial arms, and thorax as determined by either microscopy or 
PCR, and there was no significant difference between the two methods, with the 
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exception of more positive results for bacteria on the head at 30 days and 60 days p.i., 
shown by microscopy. More importantly, there were very few significant differences 
between the number of insects positive for MU1615g and MU1615::TN118g 
(mycolactone negative), as determined by either microscopy or PCR (Table 6). Similarly, 
the external surfaces of the insects showed the highest bacterial density over time. At 1 
day p.i.,there were significantly more insect raptorial arms positive for the mycolactone-
negative strain than for the wild type (P = 0.0004). At 30 days p.i., there were 
significantly more insects with wild-type-infected raptorial arms and thoraces than there 
were mycolactone negative-infected insects (P = 0.003 and 0.0001, respectively). There 
were no significant differences between MU1615g and mycolactone-negative 
MU615::TN118g infected insects 60 days p.i. In the salivary glands and guts, the 
bacterial density decreased significantly over the 60-day period, and there was no 
significant difference between this observation and that of MU1615g infected insects.  
 
3.3 Discussion 
The hypothesis that M. ulcerans is a vectored pathogen which is transmitted to 
humans via the bite of predaceous water bugs has received considerable attention (2, 13, 
17, 24).The interpretation of the data presented in earlier studies has been complicated by 
the following three major issues: (i) the insect species used were not African species, (ii) 
the primary M. ulcerans used was not representative of the classical M. ulcerans from 
Africa, and (iii) none of the studies have provided provided comprehensive quantitative 
data on the location of the bacterium within the insect. In this study, we have used an 
African insect species that has been found to have positive PCR results for M. ulcerans in 
nature and a classical lineage strain of M. ulcerans to determine the following: (i) 
whether M. ulcerans persistently colonizes or grows within African predaceous water 
bugs, (ii) how the bacterium is partitioned within external and internal body parts, (iii) 
whether mycolactone plays a role in insect infections, and (iv) whether M. ulcerans can 
be transmitted by water bugs to prey within a food chain. Although, like Marsollier and 
colleagues, we show extensive colonization of the exoskeleton of belostomatids by M. 
ulcerans (Fig. 3.2, we do not have convincing evidence of bacterial growth and 
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replication in the internal compartments of belostomatids. We found very low numbers of 
M. ulcerans in the salivary glands of belostomatids at all times, in contrast to the work of 
Marsollier et al. We initially thought that the differential findings of our laboratory and 
those of Marsollier and colleagues might be due to the use of different lineages of M. 
ulcerans. However, when tested under comparative conditions, we found no major 
differences between the ancestral and classical strains in their abilities to associate with 
belostomatids (data not shown). 
We also ruled out the possibility that the colonization of external compartments of 
belostomatids occurred as an artifact of the infection method. In previous studies, and in 
early work in our lab, M. ulcerans bacteria were injected into blowfly larvae. During this 
procedure, inoculum leaks out of the larva, producing a significant amount of surface 
contamination which could be transferred to the insect’s raptorial arms when it grasps 
prey for feeding. We were able to avoid this problem by taking advantage of the fact that 
mosquito larvae readily ingest bacteria and in turn are consumed by predaceous water 
insects higher up the food chain. Nonetheless, in our work, as in the work of Marsollier 
and colleagues, considerable colonization of raptorial arms occurred (Fig. 3.2). 
Belostomatids use their arms for grooming their stylet as well as for grabbing prey 
(28). This behavior could also lead to colonization of the raptorial arms. In accordance 
with Marsollier and colleagues, we showed that infected insects could transmit M. 
ulcerans via feeding; however, this transfer of bacteria is most likely to have occurred 
through contact with the heavily colonized raptorial arms and other external parts rather 
than the salivary glands.  
We do not find that the mycolactone toxin plays a significant role in the ability of 
M. ulcerans to persist within insects because both toxin-positive and isogenic toxin-
negative strains persist equally. The evidence for the impaired ability of mycolactone- 
negative strains to colonize French naucorids rested on a 10-fold difference between 
wild-type and mycolactone-negative strains, which was minimal considering the length 
of the experiment (15). Despite the fact that we collected insects three times during field 
trips to Ghana, we never obtained sufficient numbers of naucorids to produce statistically 
sound data. We did, however, conduct limited studies with the small number of naucorids 
we were able to collect. Results from these studies were similar to those using 
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belostomatids in that we did not see any evidence of replication in the salivary gland, but 
the numbers of insects and time points were too few for statistical analysis. 
The presence of the numerous and complex microbial flora found in 
belostomatids, especially in the gut, made it impossible to obtain any M. ulcerans cfu. 
Despite the fact that we detected few other bacteria in the salivary glands, we did not 
obtain a culture of M. ulcerans. The long-term instability of GFP under neutral pH 
suggests that the presence of fluorescent M. ulcerans in belostomatids is consistent with 
the presence of viable organisms. We did show long-term colonization of belostomatids 
by M. ulcerans using direct smear microscopy and PCR. 
With respect to methodology, we did not always find a concordance between 
microscopy and PCR results. Similar results have been reported in other studies (1, 3, 8, 
9, 10, 19). The direct smear method of detecting acid-fast bacilli has a sensitivity range of 
between 40 to 85% and a specificity of 67 to 100% (4, 8). The degree of sensitivity of 
PCR for the detection of pathogens within specimens has rendered it the method of 
choice for most studies (19). Where false positivity has been suspected with PCR, 
microscopy has been used to confirm the accuracy of positive PCR results in some cases 
(1, 9, 10). Generally, the power of detection of the bacterium of interest is increased by 
the use of both methods. Our findings support the hypothesis that predaceous aquatic 
insects may play an important role in maintaining M. ulcerans within food webs in the 
aquatic environment (2). In this respect, external contamination of insect skeletons could 
also play a role because we have observed tadpoles grazing on the surfaces of predaceous 
water bugs in microcosm environments (H. Williamson, unpublished data). We also 
cannot rule out the possibility that belostomatids may be involved in mechanical 
transmission of M. ulcerans.  
Finally, this work suggests that M. ulcerans can live as a commensal on 
belostomatids (2, 33). It is surprising that neither mosquito larvae nor belostomatids 
suffer developmental or behavioral defects as a result of M. ulcerans infection. Likewise, 
M. ulcerans appears to survive on the exoskeleton of belostomatids and within the guts of 
mosquito larvae for long periods of time. This close association between bacterium and 
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Table 3.2: Number of infected belostomatids positive for MU1615g by microscopy 
















Table 3.4. Persistence of MU1615g in specific anatomic compartments as 








Figure 3.1: Average number of MU1615g and MU1615::TN118g bacterial cells per 
insect section.   
AFB abundance as determined by number of bacilli within 50 random viewing fields at 
1000× computed from a Most Probable Number (MPN) direct smear preparation. Y-axis, 
number of bacterial cells; x- axis, days post infection. Head (A), raptorial arms (B), 
thorax (C), salivary glands (D) and gut (E).   













Figure 3.2: Scanning elecron micrographs of uninfected (top panel) and M. ulcerans 
infected (bottom panel) belostomatids.  
(A and D) Stylet; (B) tip of raptorial arm; (C and F) setae of raptorial  arm  of  uninfected  










Figure 3.3: Abundance of MU1615g in raptorial arms, gut and salivary glands.  
Location of acid-fast (bright-field microscopy) and GFP-labeled (epiflourescence 
microscopy) MU1615g in raptorial arms, gut and salivary glands of infected insects. 
Raptorial arms at 1d (A, B) and 60d (C, D) post infection. Gut at 1d (E, F) and 60d (G, 
H) post infection. Salivary glands at 1d (I, J) and 60d (K, L) post infection.  
 Arrows indicate clusters of acid fast and fluorescent bacilli respectively  










Figure 3.4: Flow chart of experimenal design to analyze blow fly larvae exuviae for 








Figure 3.5: Presence of M. ulcerans in exuviae of maggots infected by belostomatids.  
Ziehl Neelsen stain (A and C) and observation under a GFP filter (B and D), of maggot 
exuviae collected from uninfected (A and B) and MU1615g infected (C and D) 
belostomatid post feeding. Total magnification = 1000X. Arrows indicate clusters of acid 

















Chapter 4: Experimental infection of Medaka (Oryzias latipes) 
with Mycobacterium ulcerans: A model for transmission, 




Naucorids and Belostomatids have been implicated as insect vectors of Buruli 
ulcer. Both groups of insects are aggressive predaceous hemiptera, known to attack 
and immobilize prey that may even be larger than them (40). Both insects are known 
to consume small fish. Fish in Buruli ulcer endemic water bodies have been found 
positive for the M. ulcerans DNA. About 90% of this evidence has relied on the 
identification of M. ulcerans using primers designed for the insertion sequence IS2404 
(10, 23). It has been shown, however, that IS2404 is not exclusive to M. ulcerans as 
previously thought (35, 46). Other organisms within aquatic water bodies including 
novel strains of Mycobacteria have also been found to be IS2404 positive. Recently, it 
has also been shown by variable nucleotide tandem repeat typing that the DNA 
isolated from most of the fish collected from endemic water bodies, identify novel 
mycobacterial species and not M. ulcerans (46).  
Mycobacteriosis in fish has been well documented over the years (8, 22, 31) with 
the three most important pathogenic species being M. abscessus, M. fortuitum and M. 
marinum. More recently however, outbreaks of mycobacteriosis have been reported in 
various locations along the Mediterranean Sea and the Chesapeake Bay. These 
infections have been attributed to novel mycobacterial strains including M. marinum 
DL, M. pseudoshottsii, M. chesapeake and M. shottsii, which have all been isolated 
and characterized (20, 34, 35, 42). One striking revelation is that some of these novel 
strains possess a plasmid that encodes for variants of the virulent macrolide toxin, 
mycolactone, similar to the mycolactone produced by M. ulcerans (33). Although 
putative M. ulcerans DNA has been detected in fish, the ability of M. ulcerans to 
colonize fish has not been determined experimentally. Based on this evidence we have 
investigated the capability of M. ulcerans to produce an infection in Medaka (Oryzias 
latipes).  
Medaka are small (2-3 cm long by 0.5-1cm wide) oviparous fresh water fish native 
to Asia and found primarily in Japan (38, 48). They are widely used as a laboratory 
animal in biological fields, especially useful for studying developmental biology (27, 
47). Medaka are omnivorous and can be maintained on a variety of synthetic diets, 
water fleas, nauplia of brine shrimp, aquatic worms, dried unicellular green algae and 
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large protozoa. The maximal survival lifespan of Medaka in undisturbed environments 
is reported as 5 years (11), however under laboratory conditions, Medaka can live a 
maximum of 1 year (38).  
Almost all aspects of Medaka biology have been repeatedly studied and published. 
Life-cycle, sexual behavior, spawning habits, embryological development, genetic 
inheritance, pathology, feeding habits and ecology of the fish have been well 
documented (11, 12,15). Subsequently, Medaka serves as a good model for the study 
of human disease, because they have an immune response and genes similar to humans 
(3). Medaka and human share 104 conserved systemic segments involving at least 3 
orthologous gene pairs (27). In line with these research advances are a wide range of 
resources including extensive databases in toxicology, molecular genetics, and an 
existing transgenic line. Of particular importance is the See- through (ST) Medaka 
which are devoid of most major pigments, allowing organs to be observed in living 
individuals (45). This transgenic model has been used very successfully as a tractable 
experimental model for tuberculosis pathogenesis, using Medaka as the host for M. 
marinum 1218 (3). The M. marinum 1218 infection model can be manipulated to yield 
either acute or chronic infection in a dose dependant manner. The chronic infection 
model is similar pathogenically to M. tuberculosis infections in humans, resulting in 
slow but progressive granuloma formation in the liver and kidney, as well as 
inflammation of the spleen (3).  
M. ulcerans causes a painless infection in humans and guinea pigs, characterized 
by cell death via apoptosis with no apparent immune response (14). In anole lizards, it 
produces three patterns of inflammatory response; a chronic granulomatous disease in 
which acid fast bacilli are predominantly intracellular, encapsulated granuloma, or a 
diffuse necrotizing granuloma in which most AFB are extracellular—similar to the 
characteristic
 
lesion found in human infections (25). In mice, M. ulcerans infection is 
characterized by a persistent acute inflammatory response, necrosis, AFB resulting 
from lysed phagocytic cells and nerve damage (16, 28).   
The only reported association of M. ulcerans with fish has been the detection of 
the bacterial DNA in fish collected from Buruli ulcer endemic areas. This is the first 
study to address the ability of M. ulcerans to produce an active infection in fish and 
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also provide information concerning the potential role of fish in the ecology of M. 
ulcerans.    
 
4.2 Results 
4.2.1. M. ulcerans establishes systemic infection in  Medaka  
To determine the ability of M. ulcerans to establish an initial infection in Medaka, 
infected fish were sacrificed 1 wk p.i., dissected and observed by fluorescent 
microscopy for the green fluorescent marker on MU1615g and MU1615::Tn118g.  We 
observed that the heart, kidney and liver of the infected fish fluoresced green 
compared to control (Fig 4.1 and data not shown) regardless of the dose of inocula 
administered. To further substantiate our findings, the dissected organs were 
homogenized and subjected to microscopy. Wet mounts of the homogenized organs 
viewed under an epifluorescent microscope revealed the presence of Gfp expressing 
bacteria (data not shown). Smears made from all dissected organs and stained with 
Ziehl – Neelsen also revealed the presence of acid-fast bacilli (Tables 5.1and 4.2).  
This observation was also comparable to the detection of bacteria DNA within the 
organs via polymerase chain reaction (Table 4.1 and 4.2). The fact that bacteria were 
present in all organs assayed suggests that M. ulcerans produces a systemic infection 
in fish, similar to M. marinum strains. 
4.2.2. M. ulcerans is both intracellular and extracellular in Medaka  
In human and guinea pig infection, M. ulcerans is largely extracellular in the 
lesions produced and does not form granulomas like other pathogenic mycobacterial 
infections. To determine the histopathology of M. ulcerans in Medaka, infected fish 
were sacrificed at 1, 8 and 23 wks p.i., fixed and stained with Ziehl-Neelsen and 
hematoxylin and eosin. M. marinum 1218g and MMDL infected medaka were used as 
positive controls. Negative control PBS-infected fish showed no presence of acid-fast 
bacilli or pronounced inflammatory response at all time points (Fig 4.2 A and B). 
MU1615 infected medaka were positive for very few intracellular acid-fast bacteria in 
the kidney, spleen and liver (Fig. 4.2 C) and data not shown) but showed little 
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inflammatory response (Fig 4.2 D). There were pockets of extracellular bacteria 
scattered in the guts of infected fish (Fig. 4.3 E and F). MU1615::Tn118g infected 
Medaka showed scattered pockets of intracellular and extracellular acid-fast bacteria 
diffuse inflammatory response in the kidneys and spleen (Fig 4.2 E and F, and data not 
shown). As was expected in both strains of M. marinum infected Medaka, acid-fast 
bacilli were both intracellular and extracellular (Fig 4.2 G, I and Fig. 4.3 C, E) with 
loosely associated granuloma formation in 1218g (Fig. 4.2 H and Fig. 4.3 D) to well 
organized granuloma in MMDL (Fig. 4.2 J and Fig. 4.3 F) (3, 44). 
4.2.3. M. ulcerans is avirulent in Medaka compared to M. marinum  
M. marinum is lethal to fish at concentrations above 10
5
 cfu and produces chronic 
granulomatous disease at concentrations below 10
3
 cfu (3, 18, 39). To determine 
whether M. ulcerans is pathogenic to Medaka, inocula was administered to the fish in 




) and observed over time for the development of 
disease and subsequently death. Even at the highest dose of 10
8
, both MU1615g and 
MU1615::Tn118g infected fish exhibited no gross signs of disease and survived up to 





M. ulcerans more than 70% infected fish survived up to 23 wks p.i, comparable to 
PBS control fish (Fig 4.6 and 4.7). In stark contrast to the above, 1218g infected fish 
all died before the end of the study and this occurred in a dose dependent manner. 




 cfu all died by 2 wks pi and 1wk 
p.i. respectively (Fig. 4.5A and 4.6). A similar observation was made for Medaka 
infected with MMDL, however the time to death was delayed in these fish as compared 
to M. marinum infected fish (Fig 4.5B and 4.6).  
4.2.4. Mycolactone is not required for M. ulcerans persistence in Medaka  
The pathogenicity of M. ulcerans has been attributed to the presence of the virulent 
toxin mycolactone produced by the bacteria. To determine the effect of mycolactone 
on the pathogenesis of M. ulcerans in Medaka, a mycolactone negative strain was 
used. Fish infected with either the wild type or the mycolactone negative M. ulcerans 
exhibited similar  survival responses (Fig. 4.6, and data not shown). There was no 
significant difference in the numbers of fish that were positive for either bacteria at all 
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the time points assessed in this study (Tables 4.1 and 4.2). Even though Ziehl-Neelsen 
stain revealed more visible bacteria in MU1615::Tn118g infected Medaka compared 
to MU1615g Medaka in some cases, the amount of inflammatory response generated 
was comparable (Fig 4.2 and 4.3). Both strains had pockets of bacteria within the guts 
and few bacteria in the liver, heart and spleen  
4.2.5. M. ulcerans does not appear to replicate within Medaka  
M. marinum and M. fortuitum have been shown to replicate within both naturally 
and artificially infected fish (37, 41). These bacteria can be successfully isolated from 
infected fish due to the high numbers that result from colonization and replication. To 
determine if M. ulcerans replicates within Medaka, we tried to culture the bacteria 
from the organs of infected fish. However, our efforts were frustrated due to the 
overgrowth of faster growing bacteria native to Medaka. We therefore determined the 
increase in M. ulcerans DNA in infected Medaka over time using quantitative PCR 
and primers designed to amplify the enoyl reductase gene of the mycolactone 
producing plasmid. Our data suggests that there is no significant increase of M. 
ulcerans within Medaka over time (Fig 4.8 and 4.9). Rather, there was a slight but 




 cfu MU1615g and 10
4
 cfu 
MU1615::Tn118g between 1 and 8 wks p.i.  There was a significant decrease however 
in the Medaka infected with 10
8
 cfu of MU1615::Tn118g. 
 
4.3. Discussion 
M. marinum, the progenitor of M. ulcerans, is a well characterized fish pathogen 
that successfully colonizes and replicates within infected fish (4, 9) and can be isolated 
by culture from water and fish. Occasionally, M. marinum may cause human disease 
when introduced via broken skin. The disease in man is characterized by granuloma 
formation localized to the site of infection and histopathology reveals primarily 
intracellular bacteria (8). On the other hand, M. ulcerans infection in man is localized 
with the formation of lesions due to necrosis of the subcutaneous fat tissue and 
bacteria are mostly extracellular (17, 19, 24). M. marinum has almost 98% sequence 
identity with most genes in M. ulcerans, but lacks the mycolactone producing plasmid 
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responsible for virulence. Also it appears that M. ulcerans is going through an 
evolutionary bottle neck by the loss of metabolic and stress response genes suggestive 
of the adaptation of the bacteria to a novel environmental niche (21).  
Although the ecology and mode of transmission still remains unknown, the 
association of M. ulcerans with slow moving water in all geographic areas where it has 
been identified is the one major risk factor (1, 2, 5). M. ulcerans, however, cannot 
survive in water (personal communication, Pamela Small) and hence needs a host or 
reservoir within the environment where it can colonize and actively replicate. A wide 
scale study of various environmental organisms within water bodies in M. ulcerans 
endemic communities has revealed a high association of the bacterial DNA with 
biofilm, water filtrate, and pseudophytes (glass slides) (46). M. ulcerans DNA has also 
been identified in a wide range of aquatic invertebrates, of particular interest are 
Naucorids and Belostomatids (26, 29, 46), and fish (10, 23), all collected from M. 
ulcerans endemic water bodies. The diversity involved with the range of organisms 
positive for DNA suggests the possibility of transfer of M. ulcerans in a very complex 
food web within water bodies. As part of efforts to identify potential biological 
reservoirs of M. ulcerans in the environment, we have established  models for further 
understanding the interactions between M. ulcerans and fish by the following: (i) 
artificially infecting Japanese Medaka with M. ulcerans, (ii) determining the 
pathogenicity of M. ulcerans in medaka, (iii) determining the role of mycolcatone in 
Medaka infection and (iv) determining whether M. ulcerans can actively colonize and 
replicate in Medaka. This is the first study to address the possibility of M. ulcerans to 
survive and replicate in fish 
Our data suggests that M. ulcerans is capable of establishing an early infection in 
Medaka (Fig 4.1).  We show by fluorescence microscopy that the infection is systemic 
by 1 wk p.i., spreading to the organs following intraperitonial injection of the inocula. 
We noticed that the Gfp signal was pronounced in MU1615::Tn118g infected fish 
compared to MU1615g and this is because the mycolactone quenches the fluorescence 
in the latter. Both wild type and mycolactone negative M. ulcerans can also be 
detected intracellularly and extracellularly within the kidney, gut, heart, spleen and 
liver of infected fish via acid-fast staining. These results are comparable to the early 
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systematic spread of M. marinum in artificially infected fish following intraperitoneal 
inoculation (3, 6, 13, 30, 32).  
We also determined the pathology of M. ulcerans in medaka using increasing 
doses of bacteria for inoclua. Whereas an inoculum of 10
6
 cfu of M. marinum results 
in an LD50 by 1 wk p.i. (3), medaka injected with 10
8
 cfu of M. ulcerans, both wild 
type and mycolactone negative mutant, survived the entire 8 weeks of study (Fig 4. 6). 
Medaka infected with lower doses of M. marinum eventually develop a chronic 
infection characterized by well organized granuloma formation in the kidneys, livers 
and spleen, however there are no external signs of disease such as lesion formation. In 
M. ulcerans infection, there is no granuloma formation but there is the presence of 
scattered pockets of bacteria within the kidney, guts and peritoneum of infected fish. 
There is also a lack of pronounced inflammatory response and the fish appear healthy 
looking (Fig5.2). This observation may be different in other fish as hosts. For instance 
in M. marinum infection of zebra fish and gold fish, even though low doses result in 
chronic disease, infected fish develop lesions and appear bloated in comparison to 
control (3, 30, 41).  In addition to these observations, mycolactone does not appear to 
confer additional virulence to M. ulcerans pathogenicity to Medaka. Our data shows 
no statistically significant difference between the genome forming units of both strains 
at 1, 8 and 23 wks p.i (Fig 4.8 and 4.9). Again, these results may be different in a 
different breed of fish. 
A key finding from this study is that M. ulcerans does not appear to replicate in 
Medaka. Acid fast bacteria could be identified in fish sacrificed at 8 and 23 wks p.i., 
however, in comparison with M. marinum infected fish, there was no significant 
increase in the number of bacilli observed. Since we were unable to culture back form 
infected fish, we used PCR to determine increase in genome forming units of M. 
ulcerans. Our data shows an insignificant decrease in both wild type and mycolactone 
negative M. ulcerans (Fig 4.8 and 4.9). In order to avoid the bias conferred by the 
different growth rates of M. ulcerans and M. marinum 1218, M. marinum DL was used 
as a control. This fish pathogen produces mycolactone F, and is also classified as a 
slow grower. M. marinum DL fish infected with 10
8
 cfu all died by 10 days post 
infection, and low dose infected medaka, although not showing outward signs of 
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lesion formation and bloating, exhibited pronounced and well organized granuloma 
formation in the kidneys, liver and, spleen (Fig 4.2 and 4.3). Pockets of intracellular 
and extracellular acid fast bacilli were also identified within the granulomas. It is 
unclear whether the resulting pathology is due to mycolactone F or other 
immunogenic/virulent proteins in M. marinum DL. There have been conflicting reports 
on the virulence of M.marinum DL in fish compared to wild type M. marinum (20, 43, 
44). 
Our findings are novel and relevant to the elucidation of potential environmental 
reservoirs of M. ulcerans. To date, the association of M. ulcerans with fish has purely 
been based on the identification of DNA using PCR and primers designed to amplify 
the insertion sequence IS2404, previously thought to be unique to M. ulcerans (10, 
23). Recent studies have revealed that this insertion sequence is present in other 
organisms, particularly novel species of slow growing mycobacteria that also have the 
mycolactone producing plasmid (35, 46). The latter discovery has also fueled the 
discussions as to the ability of M. ulcerans to colonize fish. This study is the first of its 
kind to describe the interactions that occur between M. ulcerans and fish. We cannot 
rule out the possibility of fish being reservoirs in the transmission chain because it 
appears that M. ulcerans persists in infected medaka, but we do not see any increase in 
bacterial load over time. The infection may be transient in Medaka but have a different 
characteristic is other laboratory fish models such as zebra fish and gold fish. It is 
possible that those host systems may elucidate a finer differentiation of acute and 
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Table 4.1: Infected fish (10
4
) sections positive for acid fast bacilli and bacterial DNA 
(PCR) at 7 and 60dpi respectively 
 
  MU1615g  MU1615::Tn118g  MMDL  
 DAYS P.I.  7  60  7  60  7  60  
GUT  Microscopy  3/4  4/4  3/4  4/4  4/4  4/4  
 PCR  1/4  4/4  2/4  2/4  4/4  4/4  
HEART  Microscopy  0/4  1/4  1/4  2/4  1/4  4/4  
 PCR  2/4  2/4  2/4  1/4  0/4  4/4  
KIDNEY  Microscopy  3/4  2/4  2/4  3/4  1/4  4/4  
 PCR  3/4  2/4  3/4  2/4  1/4  4/4  
LIVER  Microscopy  1/4  3/4  1/4  4/4  3/4  4/4  
 PCR  1/4  4/4  2/4  1/4  2/4  4/4  
CARCASS  Microscopy  3/4  4/4  3/4  4/4  4/4  4/4  
 PCR  4/4  4/4  3/4  2/4  4/4  4/4  
SPLEEN  Microscopy  0/4  2/4  0/4  4/4  1/4  4/4  




Table 4.2: Infected fish (10
8
) sections positive for acid fast bacilli and bacterial DNA 
(PCR) at 7 and 60dpi respectively 
 
  MU1615g  MU1615::Tn118g  MMDL  
 DAYS P.I.  7  60  7  60  7  60  
GUT  Microscopy  3/4  3/4  4/4  4/4  4/4  4/4  
 PCR  3/4  2/4  4/4  4/4  3/4  4/4  
HEART  Microscopy  1/4  2/4  1/4  4/4  3/4  4/4  
 PCR  3/4  3/4  1/4  4/4  2/4  4/4  
KIDNEY  Microscopy  3/4  3/4  3/4  4/4  2/4  4/4  
 PCR  3/4  3/4  3/4  4/4  2/4  4/4  
LIVER  Microscopy  2/4  3/4  1/4  4/4  4/4  4/4  
 PCR  3/4  2/4  3/4  4/4  4/4  4/4  
CARCASS  Microscopy  3/4  3/4  4/4  4/4  4/4  4/4  
 PCR  3/4  3/4  4/4  4/4  4/4  4/4  
SPLEEN  Microscopy  3/4  3/4  3/4  4/4  2/4  4/4  






Figure 4.1: Initial establishment of infection of Medaka by fluorescent microscopy.  
Dissected organs from 10
8
 cfu MU1615g (top panel) and MU1615::Tn118g (bottom 
panel) infected medaka were examined for Gfp expressing bacteria 1 wk post-infection. 
A, C, E and G – bright field; B, D, F and H – fluorescent filter. A, B, E and F - liver; C, 
D, G and H – kidney. 
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Figure 4.2: Representative histopathology of Medaka infected with 10
4
 cfu of 
different strains of mycobacteria 8 wks post-infection.  
All sections were fixed and stained with Ziehl – Neelsen stain (left panels) and 
hematoxylin and eosin stain (right panels). (A and B) PBS negative control. (C and D) 
1218g infected Medaka showing loosely associated granuloma (D) with intracellular and 
extracellular pockets of bacteria (C – arrow and inset). (E and F) MMDL infected 
Medaka showing well organized granuloma with necrotic centers (F – arrow) surrounded 
by bacteria. (G and H) MU1615g infected Medaka showing little inflammatory response 
(H) with few intracellular bacteria (G- arrow and inset). (I and J) MU1615::Tn118g 
infected Medaka showing diffuse inflammatory response (J) and scattered pockets of 
intracellular and extracellular bacteria (I – arrow and inset). Total magnification, ×200 for 





Figure 4.3: Mycobacteria strains produce systemic intracellular and extracellular 
infection in Medaka.   
Histopathology of sections fixed and stained with Ziehl – Neelsen (left panels) and 
hematoxylin and eosin (right panels) for Medaka infected with 10
8
 cfu. (A and B) Gut of 
MU1615::Tn118g infected Medaka showing scattered extracellular bacteria (arrows). (C 
and D) Liver of 1218g infected Medaka showing well organized granuloma (D – arrow) 
surrounded by bacteria (C-arrow).  (E and F) Gut of MU1615g infected Medaka showing 
scattered extracellular bacteria (arrows). (G and H) Spleen of MMDL infected Medaka 
showing diffuse granuloma (H-arrow) with mostly intracellular bacteria. Magnification, 





   
Figure 4.4:  Gross morphology of Medaka post infection. 
(A) Medaka injected with 30µl of PBS (negative control) at 8 wks post infection.  
(B) Medaka injected with 10
8
 cfu MU1615g at 8 wks post-infection show no signs of 
disease or lesions. Scale bars = 100mm
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Figure 4.5: Gross morphology of Medaka post infection. 
 (A) Medaka injected with  10
8 
of 1218g at 4 wks post infection. (B) Medaka injected 
with 10
8






Figure 4.6: Percent survival of Medaka infected with 10
4
 (A) and 10
8
 (B) cfu of 





Figure 5.7: Percent survival of Medaka infected with 10
4
 cfu of MU1615g and 





Figure 4.8: Mycobacterium ulcerans persists but does not appear to replicate in 
Medaka (Experimental design 1).  
Mean log genome forming units (gfu) of MU1615g and MU1615::Tn118g infected (10
4
 
cfu) Medaka at 1, 8 and 23 wks p.i for ER-PCR positive Medaka as determined by qPCR 
using an internal probe for the ER gene. Data are means and standard deviations of the 






Figure 4.9:  Mycobacterium ulcerans persists but does not appear to replicate in 
Medaka (Experimental design 2). 
Mean log genome forming units (GFU) of MU1615g and MU1615::Tn118g infected 
Medaka at 1 and 8wks p.i for ER-PCR positive Medaka as determined by qPCR using an 
internal probe for the ER gene. Data are means and standard deviations of the values 
obtained from infected Medaka. P>0.05 for both strains (Mann Whitney test). R2 = 0.995 
















The ability of mycobacteria to colonize a eukaryotic host involves a long history of 
co-evolution and adaptation. In this process, the more rapid generation time of the 
bacteria compared to the host has enabled bacteria in many cases to adapt to their hosts 
without causing lethal infections.  The hallmark symptom of mycobacterial infection 
in humans, fish and laboratory animals is the formation of granulomas (6). Granuloma 
formation is an immune mediated response used by the host to trap pathogens and 
other foreign substances. The primary cells involved in granuloma formation in 
mycobacterial infections are macrophages, but other cells such as lymphocytes, 
fibroblasts and bacteria are also important (1). The classical model of granuloma 
formation has been perceived as a host-protective event to prevent the spread of the 
infection (32, 39). However, recent data suggests that granulomas also play a role in 
expanding bacterial infection (7). Employing both in vitro and in vitro assays, 
researchers have shown that M. leprae, M .tuberculosis, M. avium and M. marinum 
can enter macrophages and subsequently replicate within phagosomes by interrupting 
phago-lysosome formation (4, 8, 13, 26 30).  
M. marinum infection in fish has been widely used as a surrogate model for 
understanding the host-pathogen interactions between M. tuberculosis and its human 
host (3, 5, 7, 29, 39). It is pathogenic mycobacteria, closely related to M. tuberculosis 
with a much shorter generation time and has been used successfully in both in vivo and 
in vitro experiments. Since fish are natural hosts for M. marinum infection, their 
macrophages have been used to further tease out specific interactions that occur during 
acute and chronic infection (10, 15, 41). Macrophages are ubiquitously distributed in 
tissue and play a key role in the early immune response as well as in adaptive 
immunity. They are key mediators of the inflammatory response both in acute and 
chronic infection.  
In humans, most M. marinum infections are cutaneous because M. marinum like 
M. ulcerans has a restricted low temperature growth requirement. M. marinum is very 
closely related to M. ulcerans and is thought to represent the ancestral line from which 
M. ulcerans evolved.  There is 98% sequence identity of the 16SrRNA genes from M. 
marinum and M. ulcerans, and equally high homology between housekeeping and 
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structural genes from the two species (22, 23, 24, 31, 37, 38). With the ongoing search 
for the environmental reservoir of M. ulcerans and the phylogenetic relationship 
between M. marinum and M. ulcerans, the question has been asked whether fish can 
be a candidate involved in the transmission process or provide an ampilying reservoir 
in the environment. There have been reports of potential of M. ulcerans DNA in fish. 
Identification of M. ulcerans DNA have been based on identification of an insertion 
sequence IS2404 in DNA extracted from fish collected in Buruli ulcer endemic areas 
(9).  It has been shown recently that the IS2404 insertion sequence is not unique to M. 
ulcerans and is found in other organisms as well in other mycolactone producing 
mycobacteria which cause infection in fish and frogs. In this work we have shown 
experimentally that M.ulcerans does not replicate or cause disease in fish. M. ulcerans 
strains are believed to have evolved from M. marinum through reductive evolution 
(22, 23, 24, 32).  Though through evolution, loss of genes makes M. ulcerans no 
longer able to infect fish, acquisition of mycolactone cannot compensate for this (37, 
38). This raises two hypotheses why M. ulcerans does not colonize fish; (i) because 
mycolactone is not toxic for fish cells or (ii) because the genome reduction has 
resulted in loss of genes necessary for pathogenesis in fish. We have tested the effects 
of mycolactone on fish cells to address the first hypothesis. 
Many models have been developed for studying the pathogenesis of M. ulceranss 
including guinea pigs, mice, bats, armadillos and anole lizards.  The best disease 
model for understanding M. ulcerans pathogenesis is a guinea pig dermal model, in 
which lesions develop as a result of mycolactone secreted by largely extracellular 
bacteria (17, 18, 19, 20, 34). M. ulcerans causes a painless infection in humans and 
guinea pigs, characterized by cell death via apoptosis with no apparent immune 
response (17). In anole lizards, it produces three patterns of inflammatory response; a 
chronic granulomatous disease in which acid fast bacilli are predominantly 
intracellular, encapsulated granuloma, or a diffuse necrotizing granuloma in which 
most AFB are extracellular—similar to the characteristic
 
lesion found in human 
infections (25). In mice, M. ulcerans infection is characterized by a persistent acute 
inflammatory response, necrosis, AFB resulting from lysed phagocytic cells and nerve 
damage (18, 27).   
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We have developed an in vitro model for understanding M. ulcerans pathogenesis 
as a result of mycolactone using gold fish (Cyprinus carpio) macrophages (CLC). This 
cell line has been well characterized (15) and is used as a model for mycobacterial 
host-pathogen interations (10).  The cell line has an optimal growth temperature of 
28°C, which is ideal for M. ulcerans growth. It has been shown that M. marinum can 
enter and replicate efficiently in CLC cells whiles M. smegmatis is killed 
intracellularly (10).  We used acetone solubule lipids (ASLs)  of 3 different congeners 
of mycolcatone; A/B produced by the African and Malaysian strains of M. ulcerans, E 
produced by M. liflandii which cause disease in frogs and F produced by M. marinum 
DL 240490 and M. pseudoshotsii which causes disease in fish.  Acetone solubule 
lipids extracted from these mycobacteria are described as partially purified 
mycolactone and the sole activity of these lipids is due to mycolactone (16).This is the 




5.2.1. Mycolactone is cytotoxic to CLC cells in vitro 
The cytotoxic effects of different congeners of mycolactone have been described for a 
variety of cultured cells including mouse fibroblasts and human neutrophils (2, 16, 17, 
31, 34, 35). Mycolactone cytotoxicity is characterized by rapid necrosis at concentrations 
above 1 µg/ml within 4 h and delayed apoptosis at concentrations as low as 1ng/ml 
within 24 h.  To determine the effect of mycolactone on CLC cells, acetone soluble lipids 
from MU1615, MMDL and XL5 was added in a dose dependent manner to a semi-
confluent layer of CLC cells and observed microscopically for their distinct phenotypes. 
At concentrations above 10µg/ml, mycolactone A/B treated cells were visibly rounded 
and swollen by 24 h p.i. compared to cells treated with an ethanol control. This 
phenotype is significant of necrosis. At 10ng, cells treated with mycolactone A/B had 
mostly lost the confluent monlayer appeared apoptotic (Fig. 5.1).  By 48 h post treatment, 
the cell monolayer had completely detached. Cytotoxic effects were also observed with 
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mycolactone F and E treated cells, however, the phenotype differed slightly from 
mycolactone A/B treated cells. At concentrations of 10µg and above, mycolactone E and 
F treated cells appeared mostly apoptotic with condensed nuclei with loss of cell structure 
(Fig. 5.1). These observations were also made for cells treated with mycolactone 
concentrations below 100ng, but were delayed. Also, at low concentrations of 
mycolactone E and F treated cells, some cells were able to regain their morphology after 
48 h.  
To determine the mechanism of mycolactone – mediated cell death by mycolactones 
A/B, E and F, we added acetone soluble lipids from MU1615, XL5 and MMDL to a 
semi-confluent layer of CLC cells in a dose dependent manner and tested for the ability 
to produce apoptosis and necrosis. Apoptosis is characterized by nucleosome enrichment 
and clearing of the cytoplasm, and was quantified using an ELISA kit at 24h post 
treatment with mycolactone. There was a dose dependent apoptotic effect on 
mycolactone A/B and F treated cells (Fig. 5.2). At concentrations of 100µg and 10µg, 
mycolactone A/B and F treated cells were at least 2-fold more apoptotic than 
mycolactone E treated cells. At the lowest concentration of 10ng there was limited 
apoptosis with no significant difference between the congener of mycolactone used. 
Mycolactone E treated cells did not appear to have marked differences in apoptosis 
regardless of the concentration of mycolactone used.  
Necrosis of cells treated with mycolactone is characterized by cell rounding and 
swelling followed by membrane permeabilization and cell lysis. This phenotype was 
quantified by the release of LDH during cell lysis after treatment with mycolactone for 24 
h. Mycolactone A/B treated cells exhibited the highest amount of apoptosis at 100µg and 
this amount significantly decreased with decreasing doses of mycolactone. Conversely, 
both mycolactone E and F treated cells releases significantly low amounts of LDH at 
100µg. At all other concentrations, there was no significant difference between the 
amounts of apoptotic cells regardless of the mycolactone congener used. These results 
suggest that mycolactone A/B – mediated cell death is via both apoptosis and necrosis 
whereas cell death by mycolactones E and F is mostly mediated via apoptosis. It is also 
evident from these results that mycolactone A/B exhibits a more potent effect on CLC 





The activity of mycolactone A/B on human macrophage and neutrophils, and mouse 
macrophage and fibroblasts has been investigated (2, 16, 30). The hallmark cytotoxic 
phenotypes include cell rounding and swelling with subsequent cell lysis at high 
concentrations and eccentric condensed nuclei with cleared cytoplasms at low 
concentrations.  Further analysis shows that mycolactone causes cell death by both 
necrosis and apoptosis. These events explain to a large extent the localization of M. 
ulcerans at the site of infection, the non-systematic nature of the disease and the 
observation of extracellular bacilli in histopathological sections of fixed lesion tissue. In 
earlier studies we find that M. ulcerans does not cause disease in fish. Conversely, M. 
marinum DL causes disease in fish and makes mycolactone F whilst M. liflandii causes 
disease in frogs and makes mycolactone E. We are uncertain as to whether the lack of 
disease is due to the loss of genes in M. ulcerans or that mycolactone is not cytotoxic to 
fish cells. In order to understand the pathogenic potential of M. ulcerans to fish, we have 
investigated the toxicity of mycolactone for fish cells using CLC macrophages from 
goldfish. This model system has been used for understanding M. marinum pathogenesis 
as a surrogate model for M. tuberculosis pathogenesis (10). Studies of the immune 
defense mechanisms of fish have shown significant similarity with those of mammalian 
systems (11, 12). Fish have B and T – like lymphocytes, non specific cytotoxic cells 
(NK-like cells) and phagocytic cells including macrophages (11, 12). The latter have 
been shown to be involved in first line defenses just like in mammalian systems and are 
ubiquitously distributed throughout the fish (40).  
Our data suggests that all three congeners of mycolatone are cytotoxic to CLC cells in 
vitro. The potency of mycolactone E and F appear to be reduced compared to that of 
mycolactone A/B. These results have been corroborated by a previous study which also 
showed a fold decrease in potency of mycolactone F on mouse fibrolasts (L929 cells) as 
compared to mycolactone A/B (31). Structurally, all three mycolactone make the same 
core but differ slightly in the side chain (28). Mycolactone A/B has the longest side chain 
of the three (15C) and has a hydroxyl group on carbon 12 that is absent in the other two 
congeners. Mycolatone F has the shortest side chain (13C), whilst mycolactone E has a 
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14 carbon side chain. The differences in the side chains have been associated with the 
level of potency of the mycolactones in their respective hosts. However, no study has 
been done to understand the relative degree of toxicity of each mycolactone within the 
same host.  
We also have characterized the mechanism of CLC cell death due to mycolactone. We 
show that cell- mediated death due to mycolactone A/B is mostly by necrosis at high 
concentrations and apoptosis at low concentrations and is dose dependent. Again this 
phenomenon has been described for other cell types and our results are in concordance 
with previous observations (2, 16, 31).  These results further support localization of the 
infection and the subsequent lack of dissemination because all the first line immune 
defense cells that take up the bacteria upon infection are killed by mycolactone. In 
contrast, we have observed that cell - mediated death due to mycolactones E and F is 
characterized largely by apoptosis. This might explain why M. marinum DL, the strain 
that makes mycolactone F, is able to cause disease in fish by the formation of granuloma.  
These observations support the fact that mycolactone A/B is the most potent congener of 
mycolactone.  
In conclusion, we have investigated virulence of M. ulcerans for fish in two ways; (i) a 
fish model in vivo and (ii) a cell model in vitro. Studies conducted in our lab suggest that 
M. ulcerans may not be pathogenic in fish (this work).  In contrast we have evidence that 
CLC macrophages from goldfish are susceptible to mycolactones. If mycolactone is made 
by M. ulcerans in vivo in fish, early cytotoxic events due to mycolactone A/B can alter 
the ability of M. ulcerans to replicate within fish macrophages and hence the inability of 
M. ulcerans to produce disease in fish. In contrast M. marinum DL, which makes 
mycolacttone F causes disease in fish. It is possible that the later has evolved in fish and 
has maintained it tropism for fish cells whilst M. ulcerans has evolved in other hosts and 
has subsequently lost its abitllity to colonize fish. 
 Other immune cells may also confer a supportive role in containing the infection 
caused by M. ulcerans. Generally, mycobacterial species are capable of being 
internalized by macrophages and epithelial cells, however, non-pathogenic strains are 
readily killed by the cell defense mechanisms (21, 34, 35). Pathogenic species on the 
other hand can overcome these defense mechanisms and subsequently replicate within 
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infected cells (26, 29). It is possible that the absence of disease in M. ulcerans infected 
fish could be due to the lesions in the chromosome of M. ulcerans created during its 
reductive evolution from M. marinum. Another possibility is that mycolactone is 
regulated in vivo and is not being made by M. ulcerans in fish, or if it is being made, the 
phagocytic cells are immediately killed by mycolactone and hence the bacteria cannot 
replicate and are subsequently killed. In human and guinea pig infections where 
mycolactone is being actively secreted, there are both apoptotic and necrotic cells. In 
histological sections of M. ulcerans infected Medaka, this observation is absent and there 
is very little influx of immune cells in areas where bacteria are found, suggestive of the 
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Figure 5.1: Concentration dependent cytotoxicity of different congeners of 






Figure 5.2: Cytotoxicity of mycolactone measured by LDH release and nucleosome 
enrichment. 
(A) Culture supernatants were collected from wells containing CLC cells 4 h after 
treatment with mycolactone and the amount of LDH was measured using a Cytotox 96 
assay kit (Promega). Data are means and standard deviations of the values obtained from 
triplicate samples; P>0.05 for all concentrations (Student’s t test). (B) Apoptosis was 
assessed at 24 h with the cell death detection enzyme-linked immunosorbent assay kit 
(Roche) and expressed as fold enrichment of nucleosomes. Data are means and standard 
deviations of the values obtained from triplicate samples; P>0.05 for all concentrations 




















Chapter 6: Identification of Native Insect Bacteria Using 




Naucoridae and Belostomatidae are families of predaceous aquatic insects that 
belong to the order Hemiptera, also known as true bugs. They are found all over the 
world and there are few habitats without Hemiptera adapted to living there (9). Naucorids 
and Belostomatids thrive within a wide range of temperatures and climate conditions. 
The order is morphologically diverse. However all hemiptera have large compound eyes, 
four or five segmented antennae and have mouthparts that have been adapted for piercing 
or sucking. Their mandibles and maxillae are modified as needle-like stylets with two 
canals; one for delivering saliva and one for sucking fluid (11). The predatory suborders, 
to which Naucorids and Belostomatids belong, have well developed raptorial arms with 
which they grab and immobilize their prey prior to injection of paralyzing saliva.  
Naucorids are most common in the tropics and there are about 150 described 
species (22). The most common genera include Ambrysus, Aphelocherirus, Laccocoris, 
Pelocoris and Naucoris of which the latter is dominant in Africa (23). There are 
approximately 200 described species of belostomatids and the most common genera are 
Belostoma, Abedus, Lethocerus and Diplonychus. The latter is dominant in Africa and 
prefers to live in the vegetative areas of stagnant water bodies. Previous work published 
by Portaels et al (18), found African naucorids and belostomatids among other aquatic 
non-predaceous insects to be positive for Mycobacterium. ulcerans DNA. To support this 
finding, Marsollier et al. carried out studies on naïve Naucorids collected in France, 
where he infected these insects in the laboratory with M. ulcerans and followed the 
infection over a period of 90 days (15). He showed that the bacteria successfully 
colonized the insects, causing no growth impairment throughout this period. 
Insects are known to harbor a wide range of microbiota primarily in the gut and 
this property is useful in identifying various classes of insect- symbiont relationships (7, 
8). The associations between these microbes and insects may either be parasitic, where 
the microbes benefit at the expense of the insect, mutualistic or symbiotic where both 
insect and bacteria benefit or none of the parties are harmed respectively. In the later 
cases, the microbes help in digestion and sequestering of nutrient for the insects that are 
on sub-optimal diets (2, 5, 6, 20). Just as the case is in humans, indigenous insect bacteria 
also play a role in withstanding the colonization of the gut by non-indigenous species 
108 
 
including pathogens (3, 7, 21). Insect bacteria are also known to play an important role in 
the generation or suppression of immune responses in the insects. In mosquitoes for 
instance, there is a link between the reduction in gut bacteria and increased production of 
Plasmodium oocysts (2). There are other multitrophic interactions that exist between 
insects and their environment as a result of their indigenous microbiota. The microbes 
within the gut of insects have the ability to adapt rapidly to changes in the insect diet and 
infection by non-indigenous bacteria. This is reflected in changes in enzyme profiles and 
alterations in population dynamics following feeding (3, 4). 
Approximately 90% of insect-associated microbes have not been successfully 
cultured directly from their natural environments (1). This may be due to host specificity 
or the degree to which growth of these organisms is restricted. This problem can be 
overcome by the use of genomic approaches where organisms are identified at the DNA 
or RNA level (13, 14). These molecular methods are sufficiently accurate and are much 
less time consuming than attempts at culture. With this in mind, analysis of the normal 
flora of the naucorids and belostomatids was undertaken to provide important 
information on the potential interactions that might occur as a result of introduction of M. 
ulcerans to the insects. Information from these studies is also useful for developing 
techniques to suppress the growth of the insect normal flora in order to obtain M. 
ulcerans positive cultures. Finally identification of normal insect flora could provide a 
background for studying interactions between insect normal flora and M. ulcerans. 
 
6.2 Results 
6.2.1. Isolation and characterization of bacterial Isolates 
For the isolation and identification of bacteria native to belostomatids and 
naucorids, serial dilutions of insect section homogenates were plated on LB and M7H9 
media. LB media was used because it is rich in proteins. M7H9 mycobacterial media on 
the other hand is much less nutrient rich and was used to isolate potential native insect 
bacteria that might interfere with isolation of M. ulcerans. Bacterial colonies that formed 
in 24 – 48 h of incubation at 37°C were passaged on media up to three times in order to 
obtain pure cultures. The resulting isolates were subjected to antibiotic susceptibility tests 
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and growth on selective and differential media. Almost all of the bacteria found on and 
within the insects were gram negative (Table 6.1). No mycobacteria were isolated. The 
majority of isolates were Enterobacteriace cultured from the guts and thoraces of the 
insects. The distribution of the isolated bacteria species appeared to be random and there 
were many instances where bacteria with similar colony morphology were present in 
more than one tissue. The isolates that occurred in high frequency were Salmonella sp., 
Klebsiella sp., and Proteus sp. The only gram positive bacterium isolated was Bacillus 
sp. from the gut and raptoral arms of the insects.Approximately 90% of the isolates were 
resistant to ampicillin, penicillin, clindamycin and sulphonamides (Table 6.2). The most 
antibiotic resistant strain isolated was Burkholderia sp. This isolate was susceptible only 
to ciprofloxacin and chloramphenicol.  
6.2.2. Identification of bacterial strains using 16S rRNA sequencing 
In order to identify bacterial species that might be missed using culture dependent 
methods, the 16S ribosomal RNA was amplified directly from DNA isolated from the 
insect homogenates. Bacterial strains identified in Belostomatid homogenates are shown 
in Fig. 6.1 whilst those identified in Naucorid homogenates are shown in Fig. 6.2. 
Consistent with results from the culture dependent identification, about 80% of the 
sequenced bacteria had G+C contents between 40-50%, indicative of members of the 
family Enterobacteriaceae. In belostomatids, the most abundant bacterial strains were 
Klebsiella pneumoniae and Bukholderia cepacia (Fig 6.1). In the naucorids, there were 
no dominant bacterial strains however about 80% of the bacteria identified were 
enterobacteriaceae. There were 2 genera of gram positive bacteria; Bacillus sp. and 
Geobacillus sp. identified (Fig. 6.2). Common to both insects were Klebsiella 
pneumoniae, Serratia marscenses and Burkholderia sp.  
We assessed the percentage abundance of each bacterial species identified by anatomical 
section of the insects. As was expected the guts of both Naucorids and Belostomatids had 
the highest bacterial diversity compared to the raptoral arms and salivary glands with at 
least 30% of insects being positive for more than 4 different types of bacteria (Fig 6.3). 
The most abundant strains isolated from the guts were Proteus sp., Pseudomonas sp. and 
Comamonas sp.The thoraces also had a significant amount of bacterial diversity with the 
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most abundant species identified being Klebsiella pneumonia and Proteus vulgaris. The 
salivary glands and raptoral arms had the least amount of bacterial diversity with only 
10% of insect being positive for the identified bacteria in most cases. 
6.2.3. Phylogenetic diversity 
Phylogenetic diversity of bacteria identified by culture and by 16S rRNA 
sequencing was investigated. Bacteria were grouped according to phylotypes and the 
frequency of each occurring phylotype was scored against the total number of bacterial 
species identified (Fig. 4.4). The gamma proteobacteria phylotype occurred with the 
highest frequency among cultured isolates; 96%, and 90% for Naucorids and 
Belostomatids respectively. Among the bacterial strains identified by 16SrRNA 
sequencing, 90% and 50% respectively for Belostomatids and Naucorids were gamma 
proteobacteria. Delta proteobacteria were only identified among the sequenced isolates ad 
at low frequencies; 5% and 8% respectively for Belsotomatids and Naucorids. 
Aproximately 10% firmicutes were identified by both culture and sequencing. There was 
however no firmicute among the bacterial strains identified in Belsotomatids by 
sequencing. Beta proteobacteria were identified at a low frequency (~10%) by both 
sequencing and cutlture except among cultured bacterial isolates from Naucorids. 
6.3 Discussion 
 In this study, the bacterial prevalence and diversity within belostomatids and 
naucorids was investigated using both culture dependent and culture independent 
methods. A broader diversity was noted among the culture independent method. This is 
not surprising as approximately 90% of bacteria have not yet been cultured (13, 17). 
Using classical microbiological tests, we were able to identify 45 different bacterial 
isolates to the genus level. Among these were largely members of the family 
Enterobacteriaceae in all the sections of the insects assayed, with the most frequent 
genera being Salmonella, Klebsiella and Proteus. All three genera have been repeatedly 
identified in similar studies (6, 10, 19, 20) by culture. Most of the the isolates were 
resistant to at least one antibiotic and this may be explained by the high rate of horizontal 
gene transfer of antibiotic resistance between bacteria found in the guts of insects (12). A 
significant level of resistance was noticed for amplicillin and penicillin. These antibiotics 
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are beta lactams that are effective mostly against gram positive bacteria and some gram 
negative bacteria. These results corroborate the observation that about 90% of the isolates 
were gram negative. The most resistant strain isolated was Burkholderia cepacia. 
Burkholderia sp. are ubiquitous environmental bacteria with important pathogenic 
species associated with cystic fibrosis (1). They are also well known for their resistance 
to a wide variety of antibiotics (16). We were unable to identify the bacteria to the 
species level, however, further biochemical testing can readily differentiate between 
pathogenic and non-pathogenic genera identified in this study for example Salmonella sp. 
The bacterial strains identified via 16S rRNA sequencing also revealed a high 
frequency for members of the family Enterobacteriaceae.  Similar to data obtained from 
using culture dependent methods, there was little difference between genera of bacteria 
identified on different anatomical sections of the insects.  The most frequent bacteria 
identified in belostomatids were Klebsiella pnuemoniae and Burkholderia cepacia whilst 
there was no dominant genus among naucorids.  As was expected, the guts of both insects 
had the most diversity of bacteria compared to other sections analyzed. Surprisingly, at 
least 3 salivary glands of the insects had more than one type of bacteria isolated by both 
culture dependent and culture independent methods. This organ is relatively sterile in 
most insects and M. ulcerans has been recovered via culture from artificially infected 
naucorids due to this reason (15). 
 Other genera of interest identified in this study were, Acinetobacter, Serratia and 
Comamonas which are both associated with human disease and also ubiquitous in the 
environment. All three above genera have been identified in insects (7, 6, 8, 13). We were 
unable to isolate many of gram positive bacteria by either culture dependent or culture 
independent methods. In other studies, gram positive bacteria, especially members of the 
family Enterococcus and Streptococcus, which are somewhat fastidious bacteria, have 
been frequently isolated from the guts of insects (6, 19). The media used in initial 
isolation of bacteria plays an important role in the bacteria eventually isolated. For 
instance blood agar is used mostly in to isolation of gram positive bacteria. In our study, 
the use of LB and M7H9 may have accounted for the high amount of gram negative 
bacteria isolated. There may have been a selective bias for interesting colonies during the 
initial screening of plates. For the culture independent method, the 16S rRNA primers 
112 
 
used were considered universal for bacteria, however, they may be biased to amplify only 
certain DNA sequences than others. This discrepancy may be also be explained by the 
fact that naucorids and belostomatids are aquatic insects and may have a different 
community of native bacteria. 
We also described the phylotype diversity of bacteria present in Belostomatids 
and Naucorids. The gamma proteobacteria were the most abundant phylotype and this is 
true for other studies (14, 19, 21). The beta and delta proteobacteria were also represented 
in small amounts, however, it was surprising that no actinobacteria were identified in this 
study. M. ulcerans is a member of the actinobacteria phylum and their DNA has been 
identified in a small percentage of belostomatids and naucorids (18, 27). Evident from 
this study are the differences between bacteria identified by culture independent and 
culture dependent methods for the same sample. All four phylotypes identified in this 
study were represented in bacterial strains identified in Naucorids by 16SrRNA 
sequencing whereas only two phlyotypes were represented by culture dependent 
methods. 
 In conclusion, our data shows that there is significant native flora within 
belostomatids and naucorids. Of importance is the fact that almost 90% of the isolated 
bacteria grew well on M7H9 mycobacterial media and there will be possible interference 
with the isolation of M. ulcerans from infected belostomatids or naucorids. Also most of 
these bacteria have acquired significant resistance to most mainstream antibiotics. What 
remains unknown is whether these native bacteria confer any selective advantage or 
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Gut 1 yes yes - A/A/- + - -/-/- - Enterobacter 
Gut 2 yes no - n/a + + n/a + Burkholderia 
Gut 3 yes yes - A/K/+ + - +/+/- + Salmonella 
Gut 4 yes yes - A/K/+ + - +/+/- + Salmonella 
Gut 6 yes no - n/a + + n/a + Burkholderia 
Gut 7 yes yes - A/A/+ - + +/-/+ - E.coli 
Gut 8 yes yes + n/a + - n/a + Bacillus 
Gut 9 yes yes - A/A/+ - - +/-/+ - E.coli 
Gut 10 yes yes - A/A/+ - - +/-/+ - E.coli 
Gut 11 yes yes + n/a - - n/a + Bacillus 
Gut 12 yes yes - K/K/- - - -/-/- - Shigella 
FA 1 yes yes - A/A/- + + -/+/- + Serratia 
FA 2 yes yes - A/K/+ + - +/+/- + Salmonella 
FA 3 yes yes - A/A/+ - - +/-/+ - E.coli 
FA 5 yes yes - A/A/- + + -/+/- + Serratia 
FA 6 yes yes - K/K/- - - -/-/- - Shigella 
SG 2 yes yes - A/K/+ + - +/+/- + Salmonella 
SG 3 yes yes - A/K/+ + - +/+/- + Citrobacter 
SG 4 yes yes - A/K/+ + - +/+/- + Salmonella 
SG 5 yes yes - A/A/- + + -/+/- + Serratia 
SG 6 yes yes - A/K/+ + - +/+/- + Salmonella 
SG 7 yes yes - A/K/+ + - +/+/- + Salmonella 
SG 8 yes yes - A/K/+ + - +/+/- + Salmonella 
Tho 1 yes yes - A/A/- + + -/+/- + Serratia 
Tho 2 yes yes - A/K/+ + - +/+/- + Citrobacter 
Gut 5a yes yes - A/A/- + - -/-/- + Klebsiella 
Gut 5b yes yes - A/A/+ - - +/-/+ - E.coli 
Gut 6a yes yes - K/K/- - - -/-/- + Shigella 
Gut 6b yes yes - A/A/+ - - +/+/+ + Proteus 
FA 4a yes yes - A/A/- + - -/-/- + Klebsiella 
FA 4b yes yes - A/A/- + - -/-/- - Enterobacter 
FA 7a yes yes + n/a + - n/a + Bacillus 
FA 7b yes yes - A/A/- + + -/+/- + Serratia 
SG1a yes yes - A/K/+ + - +/+/- + Salmonella 
SG1b yes yes - A/A/- + - -/-/- + Klebsiella 
FA7aC yes yes - A/K/+ + - +/+/- + Salmonella 
FA7aY yes yes - A/A/+ - - +/+/+ + Proteus 























Gut5bs yes yes - A/A/- + - -/-/- - Enterobacter 
SG1aY yes yes - A/K/+ + - +/+/- + Citrobacter 
SG1aC yes no - A/K/+ + - +/+/- + Salmonella 
SG4COL yes yes - A/A/+ - - +/+/+ + Proteus 
SG4SWA yes yes - A/K/+ + - +/+/- + Salmonella 
SG8Y yes yes - A/A/+ - - +/+/+ + Proteus 
SG8Ca yes yes - A/A/+ - - +/+/+ + Proteus 





Table 6.2: Antibiotic testing of bacterial strains isolated using culture dependent methods 
Identification 
of section 
AM10a CB100 P10 GM10 S10 E15 TE30 CIP C30 CC2 SSS20 AN30 ID 
Gut 1 0 25 0 21 20 0 0 35 25 0 0 27 Enterobacter 
Gut 2 0 0 0 0 0 0 16 35 25 0 0 20 Burkholderia 
Gut 3 0 0 0 11 20 14 14 40 25 0 0 21 Salmonella 
Gut 4 0 0 0 13 19 12 0 32 25 0 0 21 Salmonella 
Gut 6 0 0 0 0 0 11 20 32 25 0 0 21 Burkholderia 
Gut 7 0 30 0 20 25 31 0 34 20 0 0 34 E.coli 
Gut 8 0 30 0 25 12 0 0 40 15 0 0 21 Bacillus 
Gut 9 0 27 0 31 24 32 0 40 21 0 0 32 E.coli 
Gut 10 0 30 0 26 25 31 21 44 22 0 0 30 E.coli 
Gut 11 0 30 0 24 15 0 0 43 16 0 0 25 Bacillus 
Gut 12 0 25 0 30 31 0 15 32 25 0 0 32 Shigella 
FA 1 0 0 0 33 30 0 12 45 25 0 0 21 Serratia 
FA 2 0 0 0 10 21 0 18 45 25 0 0 20 Salmonella 
FA 3 0 27 0 31 25 27 0 45 23 0 0 33 E.coli 
FA 5 0 23 0 24 17 0 0 42 24 0 0 21 Serratia 
FA 6 0 25 0 30 22 0 21 40 25 0 0 25 Shigella 
SG 2 0 0 0 25 15 12 12 40 25 0 0 30 Salmonella 
SG 3 0 30 0 23 23 0 0 44 26 0 0 31 Citrobacter 
SG 4 0 0 0 15 22 10 12 43 23 0 0 27 Salmonella 
SG 5 0 0 0 22 21 0 0 41 23 0 0 22 Serratia 
SG 6 0 0 0 11 18 11 21 40 25 0 0 25 Salmonella 
SG 7 0 0 0 12 18 14 10 32 25 0 0 23 Salmonella 






AM10a CB100 P10 GM10 S10 E15 TE30 CIP C30 CC2 SSS20 AN30 ID 
Tho 1 0 0 0 23 21 0 0 35 25 0 0 33 Serratia 
Tho 2 0 27 0 25 14 0 0 43 21 0 0 33 Citrobacter 
Gut 5a 0 30 0 17 21 0 11 42 23 0 0 24 Klebsiella 
Gut 5b 0 26 0 22 24 26 12 40 22 0 0 27 E.coli 
Gut 6a 0 24 0 30 26 0 20 38 25 0 0 5 Shigella 
Gut 6b 0 30 0 25 21 0 10 37 24 0 0 32 Proteus 
FA 4a 0 24 0 24 21 0 12 41 23 0 0 21 Klebsiella 
FA 4b 0 25 0 21 25 0 0 39 24 0 0 23 Enterobacter 
FA 7a 0 23 0 23 22 0 0 40 25 0 0 30 Bacillus 
FA 7b 0 0 0 31 21 0 0 41 25 0 0 2 Serratia 
SG1a 0 0 0 12 19 12 21 44 21 0 0 25 Salmonella 
SG1b 0 25 0 26 21 0 18 44 20 0 0 27 Klebsiella 
FA7aC 0 0 0 10 25 12 12 45 25 0 0 24 Salmonella 
FA7aY 0 24 0 23 22 0 11 45 24 0 0 31 Proteus 
Gut5bp 0 25 0 33 21 0 12 45 23 0 0 26 Klesbsiella 
Gut5bs 0 25 0 23 20 0 0 45 23 0 0 21 Enterobacter 
SG1aY 0 30 0 24 22 0 0 42 25 0 0 24 Citrobacter 
SG1aC 0 0 0 12 21 12 15 40 21 0 0 23 Salmonella 
SG4COL 0 24 0 24 22 0 12 40 25 0 0 30 Proteus 
SG4SWA 0 0 0 20 21 14 21 42 25 0 0 26 Salmonella 
SG8Y 0 25 0 26 25 0 10 38 25 0 0 31 Proteus 
SG8Ca 0 24 0 12 24 0 9 39 24 0 0 33 Proteus 





Figure 6.1: Phylogenetic tree constructed for partial 16S rRNA gene of bacterial 
strains from Belostomatids 
* Reference strains; GU126803.1| Klebsiella pneumonia, NR_029209.1| Burkholderia 






Figure 6.2: Phylogenetic tree constructed for partial 16S rRNA gene of bacterial 
strains from Naucorids 
* Reference strains; GU126803.1| Klebsiella pneumonia, NR_029209.1| Burkholderia 





   
   
Figure 6.3: Percentage of insects positive for each bacterial strains identified using 
16S rRNA sequencing 
 
























































Figure 6.4: Percentage abundance of phylotypes within culturable isolates and 16S 

























Buruli ulcer continues to remain a devastating disease in tropical rural parts of the 
world especially Africa. Both the disease and the causative organism, Mycobacterium 
ulcerans are of key interest to researchers because of the unusual patterns of the disease 
pathology and the biology of the bacterium repectively. Unlike other infections with 
environmental mycobacteria, the painless nature and slow progression of Buruli ulcer, 
makes it so devastating. Affected individuals seek health care only at the late and 
ulcerative stages of the disease. The stigma associated with the disease only goes to 
further retard its reporting. On the part of the causative organism, the fact that its DNA 
has been associated with many aquatic organisms, reveals a complex biology that makes 
it difficult to determine in which particular organism M. ulcerans is replicating. The 
hydrophobicity of the bacterium makes it concentrate at the air water interface in the 
environment and makes it readily form biofilms of the surfaces of many organisms. 
Researchers have attributed the re-emergence of Buruli ulcer to the overlapping 
ecology of man and environmental mycobacteria. Man-made environmental disturbances, 
particularly deforestastion, urbanization and sandwining as well as natural flooding that 
occur due to rainfall patterns have been implicated as risk factors in the epidemiology of 
the disease. Noteworthy in the transmission of the disease is that person-to-person 
transfer of the bacterium is rare and that man becomes infected primarily through dierect 
contact with the environment. This signifies the true environmental nature of M. 
ulcerans, implying that it does not need the human host to proliferate in nature. The 
hypothesis that trauma to the skin is necessary for the introduction of M. ulcerans to the 
host hence bears significant validity. What remains to be addressed then is the 
identification of the environmental reservoir of the bacterium and the potential vectors 
that can cause injury to the skin and ultimately deliver an infective dose of M. ulcerans to 
unsuspecting human hosts. 
Advances in research identifying various aquatic organisms that are PCR positive 
for M. ulcerans DNA suggests that the bacterium is being transferred within a complex 
food web. This implies two possibilities; (i) that the bacterium has a high diversity of 
metabolism, thus being able to proliferate in more than one organism, or (ii) that the 
126 
 
bacterium is contained within a secondary organism such as a protozoan, which is also 
associated with similar aquatic organisms as M. ulcerans. It is also important to note here 
the ongoing reductive evolution of M. ulcerans from its ancestor M. marinum. This has 
been characterized by significant genome contraction by the generation of pseudogenes 
and DNA rearrangement leading to the loss of coding sequences that may have allowed 
M. ulcerans to occupy similar niches as M. marinum. A good example is the truncation of 
the crtB locus in M. ulcerans. In M. marinum, this locus is responsible for the production 
of light induced carotenoids that protect the bacteria from direct sunlight (Stinear 2007). 
The absence of a full gene product in M. ulcerans, makes the bacterium sensitive to light 
indicating a change in its environmental niche. Other bacteria that have undergone 
significant genome contraction and niche specialization include M. leprae, Yersinia pestis 
and Bordetella pertusis (3). 
The acquisition of the mycolactone producing plasmid is thought to have occurred 
by lateral gene transfer (5), however, the specific role for the toxin in the environment 
has not been elucidated. Is it possible that the toxin confers a selective advantage for 
niche domination in the environment? Is the toxin synthesized by the bacterium in the 
environment or only in the human host? Which phenomenon occurred fisrt; the genome 
downsizing or the acquisition of the plasmid? Why are the other mycolactone producing 
mycobacteria such as M. liflandii and M. pseudoshottsii associated with definite 
environmental hosts and what is the evolutionary history between these strains and M. 
ulcerans? 
In the search for answers to the mode of transmission of M. ulcerans to man, it is 
imperative to experimentally test the findings in nature in a laboratory setting. The work 
presented in this study has sought to understand the role of insects and fish in 
transmission. We have shown that due to the waxy nature of M. ulcerans, it readily forms 
an extracellular matrix on the surface of Belostomatids, and hence can be directly 
introduced to unsuspecting humans that are accidentally bitten. We do not have 
conclusive evidence that the bacterium replicates within these insects but we cannot rule 
out the possibility of them being involved in the transfer of the bacterium in nature. The 
history with bacteria that are vectored primarily by insects involves a long evolutionary 
process of co-adaptation, and most of the insects are haematophagous. This is not the 
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case with Belostomatids or Naucorids; they are both predaceous. It is possible that 
aquatic insects may play other roles in the transmission process and future studies should 
specifically address the biology of the bacterium with respect to the biting insects. 
We also show that fish may transiently contain M. ulcerans in the environment, 
however, unlike most environmental mycobacteria, M. ulcerans does not cause disease in 
fish (Japanese Medaka). Even though M. marinum DL and M. pseudoshottsii produce 
mycolactone and cause disease in fish, M. ulcerans specifically only produces disease in 
humans. Future studies should involve identifying whether M. ulcerans is pathogenic in 
other types of fish such as zebra fish and gold fish because they might exhibit different 
immune responses. We have also shown that mycolactone is cytotoxic to fish cells in 
vitro. Although the precise molecular mechanism of mycolactone on eukaryotic cells is 
unknown, it has been shown to accumulate in the cytosol eventually leading to cell cycle 
arrest and apoptosis (4). The effects of mycolactone are also ubiquitous, and not cell 
specific. 
Despite the action of the toxin, the possibility of M. ulcerans living within 
protozoans is a hypothesis worth testing. Other environmental mycobacteria have been 
shown to replicate within Acanthamoeba (1). Recently, it was shown that mycobacteria 
are capable of foming spores (2). This may contribute to the persistence of M. ulcerans in 
the environment and also account for the dormancy and latency of the bacterium in 
nature. Much work is yet to be done to specifically understand the mode of transmission 
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